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 1
0.  Preface 
 
Symmetry is one of the most ubiquitous phenomena in our life. Normally, we are so 
used to it that we are often not even aware of the impact it has. For example, 
symmetry is often associated with beauty, most of the time unconsciously. This is 
true not only regarding works of art like Leonardo da Vinci´s “Vitruvian” or the Taj 
Mahal (Figure 0.1), but also with respect to the attractiveness of a person. 
       
Figure 0.1. Leonardo da Vinci´s “Vitruvian” and the Taj Mahal 
 
Besides this, symmetry is also a very successful design principle of life in general. 
There must be a reason why evolution chose many living things to be symmetric. 
Almost every higher organsim exhibits, at least on a macroscopic level, mirror-image 
shape. Nobody wonders, of course, why we have two eyes, two ears or two hands. 
 
Figure 0.2. Symmetric Eastern Tiger Swallowtail 
 
Nevertheless, the existence of a mirror-image relationship implies also a very subtle 
form of symmetry, namely chirality. The fact, that things can be mirror-images, but 
not superimposable, is an every day phenomenon. For example cars, one 
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“enantiomer” of which is driving in left-hand traffic countries like the UK, the other one 
on the roads of the rest of the world. Or our own body, where normally only one chiral 
form is observed, namely those with the hearts on the left side. This brings us to an 
astonishing phenomenon in living nature: the homochirality of life.  
The “enantiopurity” of humans on a macroscopic level is reflected also in the world 
of submiscroscopic dimensions. In general, nature has chosen to predominantely 
have one form of chiral molecules. That is why (L)-amino acids or (D)-sugars are 
among the most important building blocks for the generation of living systems. Not 
only on a molecular, but also on a higher level chirality can be found e.g. in α-helices 
of proteins or double-stranded DNA (Figure 0.3). 
 
                        
Figure 0.3. Chiral helices in nature: DNA-model and protein structure 
 
The question of homochirality is probably closely connected to the origin of life itself. 
Why nature was able to prefer only one form of enantiomers is still far from being 
completely understood, especially because in classical physics it was long believed, 
that the equivalence of left and right is a given thing and this was expressed in the 
conservation law of parity. Only in the second half of the last century, first steps to 
unravel this mystery were made. An important milestone was the spectacular finding 
of Yang and Lee in 1956 (Nobel price 1957), that parity is not conserved in the β-
decay of 60Co.[1] They showed, that in principle left and right need not be equal. And 
indeed, nowadays it is possible to determine energy differences of enantiomeric 
molecules resulting from parity violation.[2] Nevertheless, the effects are normally too 
small to be observable, even on a microscopic level. Since Soai´s report, however, 
on an autocatalytic system (Scheme 0.1) that creates enantiopure molecules from 
almost racemic mixtures in the 90´s of the last century, we have an impression of 
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how this strong amplification of chiral information could have been achieved by 
nature on the basis of only tiny differences.[3] 
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Scheme 0.1. Soai´s discovery of autocatalytic asymmetric amplification 
 
This is only one story in the fascinating field of chirality, but certainly one of the most 
important, touching the very basis of life and our view of the world. This was one of 
my personal motivations for this thesis, investigating the formation of certain classes 
of (in the best case) homochiral molecules and assemblies thereof. Maybe it can help 
to understand a few aspects of the always surprising nature of our world. 
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1.  Introduction 
 
1.1 Background 
 
The stereoselective synthesis of only one enantiomer is a big challenge in 
chemistry. Different disciplines of chemistry have reached different stages of 
sophistication. The by far most efficient methods involving asymmetric synthesis 
have been developed in the area of organic chemistry.[1] Today this field is in a rather 
mature stage, enabling the synthesis of incredible complex chiral strucures. The 
availability of numerous very efficient methods culminates in perhaps the most 
impressive achievements, enantioselective total syntheses of natural products[2] like 
Longithorone A[3] (Figure 1.1) or Diazonamide A[4] 
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Figure 1.1. Total synthesis of complex organic molecules 
 
The most important structural feature in chiral organic molecules is the carbon 
center with for different substituents (Figure 1.2). 
C
a
b
d
c
C
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d
c
       
Figure 1.2. Tetrahedral C-atoms with four different substituents are stereogenic centers 
 
Nevertheless, the existence of stereogenic carbon atoms is not sufficient for the 
existence of chirality, being a global property of a system. In general, the absence of 
an improper axis of rotation Sn is the requirement for a system to be chiral. Especially 
two Sn-axes are found most often, S1 (≡ mirror plane) or S2 (≡ center of inversion). 
The absence of a Sn-axis is the criterion for chirality that must be applied to the entire 
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system. Consequently, there are a number of other common motives besides 
asymmetric carbon atoms that can lead to chirality (Figures 1.3 - 1.5). 
 
b
a b
a b
ab
a
 
Figure 1.3. Axial chirality in allenes and binaphthyls 
 
R R
 
Figure 1.4. Planar chirality in paracyclophanes 
 
Figure 1.5 Helical chirality in helicenes 
 
Nowadays, it is not only possible to build up chiral organic structures with 
stoichiometric asymmetric methodolody but also through catalysis using only 
substoichiometric amounts of chiral information with sometimes surprising degrees of 
selectivity. Many problems remain unsolved, especially with respect to industrial 
application. However, in principle, most of the commonly used reaction types are 
amenable to asymmetric catalysis.[5] 
In the field of asymmetric inorganic synthesis,[6] the problem of stereoselective 
construction of chiral structures turns out to be more difficult. This is mainly due to 
the increased number of possible coordination geometries or central atoms and often 
also because of the lability of the ligands towards substitution. Carbon is in this 
respect unique among other atoms, having a strong preference for coordination 
numbers smaller than five and most importantly shows relative substitution and 
configuration stability, at least in a way to allow the isolation of defined stereoisomers 
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in many cases. The first breakthrough for inorganic stereochemistry was achieved by 
Alfred Werner as early as 1911 with the separation of enantiopure octahedral cobalt 
complexes (Scheme 1.1).[7]  
[Co(en)2(NH3)Cl]Cl2
(rac)
1. D-bromocamphersulfonic
   acid silver salt
2. HBr
Co
Cl
H3N NH2
NH2
H2N
H2N
Br2
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NH3H2N
H2N
NH2
NH2
Br2
(en =1,2-ethylendiamine)
 
Scheme 1.1. First separation of enantiomeric metal complexes by A. Werner in 1911 
 
Since then, many examples for these Werner-type chiral complexes have been 
reported. Especially octahedral metal tris-chelates [M(ab)3]n+ with bidentate ligand 
have found extensive application. With chiral, non-racemic ligands it was also 
possible to stereoselectively create complexes of this type with predetermination of 
the configuration at the metal as stereogenic center.[8] Among the most successful 
ligands are Zelewsky´s chiragen ligands (Scheme 1.2).[9] 
Ru
N
N N
N
N
N
N
N
N
N
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N N N N
=
1. [Ru(DMSO)4Cl2]
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    LiOTf
∆
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Scheme 1.2. Stereoselective formation of octahedral Ru-chiragen complexes 
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Besides the formation of chiral Werner-type compounds, chiral organometallic 
complexes have been an early subject of investigation. Soon after the discovery of 
ferrocene[10] in 1951, the first disubstitued chiral derivatives could be resolved, 
followed by a number of other reports of similar π-complexes (Figure 1.6),[11] all of 
which exhibit planar chirality. Compounds of this type have found numerous 
application in modern chemistry. 
 
Fe
O
(ref. 11a)
Cr
OC CO
CO
COOH
H3CO
(ref. 11d)
 
Figure 1.6. Early examples of resolved enantiomers of planar chiral organometallic complexes 
 
However, the occurence of chirality is not restricted to complexes with a plane as 
element of chirality. In 1969, the first organometallic complex was resolved with the 
metal as stereogenic center (Figure 1.7).[12] Since then, many other compounds of 
this type have been synthesized with a single stereochemical configuration.[13] 
 
Mn
OC NO
PPh3
PF6
 
Figure 1.7. One of the first examples of resolved chiral organometallic complexes  
 
The issue of stereochemistry becomes more and more important with the extension 
from mononuclear complexes to oligo- or polynuclear species, because an increasing 
number of stereogenic centers results in many possible diastereomeric compounds. 
This is one of the most important problems in supramolecular chemistry and has 
been dedicated a great deal of attention.[14] A complete overview of this rapidly 
growing field would require a multivolume treatise and goes way beyond the scope of 
this introduction. Nevertheless, a few selected examples should illustrate the nature 
of chirality in this area of reasearch, offering a potential degree of complexity 
comparable to organic chemistry.  
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Among the most prominent chiral structures in supramolecular chemistry are the so-
called “helicates”.[15] This term was introduced by Lehn in 1987 (Scheme 1.3),[16] 
although a few examples[15a] were known before. Helicates are oligonuclear 
assemblies of metal ions with one or more strands of bridging organic ligands in the 
form of a helix. This shape introduces an element of chirality.  
N
N
O
N
N
Cu(I) O
O
 
Scheme 1.3. Lehn´s first example of a “helicate” 
 
If non-chiral ligands are employed, normally a racemic mixture is obtained. By the 
use of enantiomerically pure ligands, Lehn was also the first to show the asymmetric 
synthesis of helicates.[17] 
Another fascinating area is the construction of chiral polyhedral three-dimensional 
structures,[18] most prominently represented by tetranuclear metal clusters with T-
symmetry.  The first examples were introduced by Saalfrank[19] using transition metal 
complexes with achiral chelating ligands. The first separation of the enantiomeric 
clusters from achiral ligands was accomplished by Raymond (Figure 1.8).[20] 
Interessingly, the clusters proved to be extraordinary stable towards racemization. 
Stack showed, that the use of chiral, non-racemic ligands can also lead to homochiral 
tetrahedral clusters, thus exhibiting complete diastereoselectivity.[21] 
          
Figure 1.8. Raymond´s enantiomerically pure tetranuclear Ga-cluster (reproduced from ref. 20b). 
 
There are many more examples for chirality in supramolecular chemistry using 
metal complexes,[22] too many to mention here. The wide field of topological chirality 
in catenanes, knots, rotaxanes, etc. also goes way beyond the limited scope of this 
introduction.[23] 
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In conclusion, the area of inorganic stereochemistry has been a rapidly evolving 
research subject through the last few decades. Especially, many complex chiral 
motives have been realized, although most of the time only as racemic mixtures. 
Nevertheless, the basis for the asymmetric generation of certain stereogenic 
elements is in most of the cases the control of the configuration at single metal 
centers. The development of methods for this purpose has therefore attracted more 
and more attention during the last years. Still, this field is far from being sufficiently 
explored and should hold a manifold of discoveries for the future. 
 
1.2 Aim of this Work 
 
The starting point for this work was the idea to design a chiral model for 
bleomycin,[24] a metal-containing glycooligo-peptide antibiotic capable of oxidative 
DNA-strand scission (Figure 1.9). 
N
N
N
MeH2N
O
NH
H2NOC
H
N
N
Fe
NH2
O2
CONH2H
H
O sugar moiety
H
linker moiety DNA binding siteH
 
Figure 1.9. The active site of bleomycin with O2 coordinated 
 
This species utilizes dioxygen for the oxidative DNA-strand scission. O2 is activated 
by an Fe(II)-metal-center, surrounded by five N-donors and having octahedral 
geometry. The activation of dioxygen at mononuclear non-heme metal centers has 
recently attracted great interest.[25] Therefore, a number of model systems for 
activated bleomycin[26] have been developed on the basis of pentadentate ligands 
(Figure 1.10). 
 10
N
H
N
O NH2
NH2
H
N
O NH
N
CO2R
OtBu
PYML
N N
R
N
NR2
H
N
O NH
N
Br
PMAH
N N
N
N
N
N
N4Py
OMe MeO
N
N
N
N
Py5
N
N N
R
N
N
R-TPEN
N
N N
N N
TACNPy2
N
NH N
N
N
O
H-PaPy3
 
Figure 1.10. Synthetic model systems for activated bleomycin 
 
While early attempts (like PYML and PMAH) resemble the structure of the active 
site of natural bleomycin very closely, the other model systems keep only the 
characteristic pyridine-containing five-N-donor-set. All of them are able to perform 
certain aspects of the bleomycin-reactivity. Nevertheless, only the deprotonated, 
monoanionic amide-ligands activate dioxygen in combination with Fe(II). In contrast,  
the Fe(III)-complexes of the other neutral ligands are usually transferred to reactive 
compounds by treatment with peroxo-reagents, like H2O2. Furthermore, besides 
bleomycin itself and the closely related, but not easily accessible PYML, no other 
ligand is chiral. Upon complexation of some of these ligands to a metal, the 
generation of stereogenic elements can be expected, but only as a racemic mixture. 
The stabilization of highly reactive metal-oxo-fragments can be achieved by 
hydrogen bonds. The first structurally characterized iron complex containing a single 
terminal oxo-ligand, reported by Borovik,[27] showed a network of stabilizing hydrogen 
bonds (Figure 1.11). 
 
Figure 1.11. H-bonds can stabilize metal-oxo-fragments 
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The past research in our group has also focussed on the utilization of secondary 
interactions for asymmetric catalysis using bis(oxazoline) ligands with additional H-
donor-groups (Scheme 1.4).[28] 
OMeO2C
OMeO2C
CO2Et
H
H
Cu(OTf)2 / L* (2 mol%)
PhNHNH2 (cat.)
N2 CO2Et
36% (91% ee, recryst: 99% ee)
L* =
N N
OO
PhPh
O O
O O
TsHN NHTs
O
Cu(OTf)2 / L* (2 mol%)
ZnEt2
O
96% (93% ee)
L* =
N N
OO
PhPh
HO OH
 
Scheme 1.4. Asymmetric catalysis via secondary interaction developed by the Reiser group. 
  
The idea was to combine the characteristic features of bleomycin with our previous 
concept of chiral ligands with stabilizing secondary H-donor sites. The following 
requirements seemed appropriate: 
 
● Pentadentate ligands with variable donor set, containing aromatic N-heterocycles 
(pyridine, pyrimidine) and providing the possibility for octahedral geometry. 
● Chiral, non-racemic ligands with secondary H-donors, preferably with C2- or higher 
symmetry. 
● Facile synthetic accessibility of the ligands, especially regarding the source of 
chirality. 
● Flexible assembly of the ligand structure to allow rapid variation of donor set and 
secondary sites. 
 
These conditions could be met by the final design proposal of the general 
structure 1 (Figure 1.12). 
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(EWG/EDG)
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O O
N
H-donor H-donor
Electronic tuning 
of the metal
Y = N-R, O, S,...
Easy variation of 
the donor set
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high directional orientation
of H-donor: -OH, -NHR,..
Modular assembly through
simple SN-combination of
electrophiles and nucleophiles
Oxazoline-moiety easily
accessible in non-racemic
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1
 
Figure 1.12. Our proposed design for chiral pentadentate ligands as bleomycin models. 
 
This structural blueprint has several specific features:  
● C2-symmetry: Introduced by Kagan[29] into asymmetric catalysis, has proved to be 
a powerful concept. 
● Oxazoline-ligands: First used by Brunner[30] in asymmetric catalysis, strongly 
coordinating to various metals, excellent accessibility from non-racemic amino 
acids 
● Flexible connection of the pyridine unit and the heterocyclic oxazolines with Y: For 
the design of 1, we combined the work of Newkome[31] (C2-symmetry of cobalt 
complexes with his achiral pentadentate ligands) and Bernauer[32] (predeter-
mination of metal-centered chirality with chiral, non-racemic pentadentate ligands) 
(Figure 1.13). 
 
N
YY
N N
Newkome
N
HNNH
O OH OHO
R R
Bernauer
(Y = O, S, NH)
 
Figure 1.13. The basis of design of 1: Newkome´s (left) and Bernauer´s ligand system (right)  
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● Pyridine: The electronic situation at the metal can be influenced by suitable 
substituents at the heteroaromatic system, as shown for the similar pyridine 
bis(oxazolines) by Nishiyama.[33] Furthermore, the pyridine serves as excellent 
chromophore for the measurement of circular dichroism (vide infra). 
● Donors in benzylic position: Offer both, good possibility for connecting modular 
subunits by SN-reactions and facile variation of the donor set. Provides high 
flexibility of the ligand which should in principle enable many coordination 
geometries. 
● The steric as well as the electronic situation at the phenyl rings can easily be 
altered through suitable choice of the achiral carboxyl component of the oxazoline. 
Highly directed introduction of H-donors on the rigid aromatic scaffold is possible. 
 
The corresponding metal complexes were modelled on a semi-empirical level (PM3-
TM, Titan 1.0.5) to get a first hint for the coordination geometry. In the first instance 
this was done not to predict the exact structures but to exclude unexpected simple 
problems for metal complexation. The obtained complexes were encouraging, so the 
decision was made to hang on to this design.  
The task of this work was to elucidate the basic coordination behavior and, because 
with complexation a couple of new stereogenic centers are introduced, the 
diastereoselectivity with regard to the configuration at the metal center (see 1.1). To 
make matters as easy as possible without losing important characteristic features, 
the blueprint 1 was truncated to the model system 2 (Figure 1.14). 
N
YY
N
O O
N
2a: Y = O
2b: Y = S
2c: Y = NMe
 
Figure 1.14. Model system investigated in this work 
 
This system proved to be in in accordance with many of our expectations. 
Nevertheless, many surprises waited for the alert beholder along the way.... 
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2.  Ligand Synthesis 
 
 
For the assembly of the ligands 2, a modular approach was developed. The 
retrosynthetic analysis (Scheme 2.1) suggests the final assembly of 2 by nucleophilic 
substitution. 
N
YY
N
O O
N
Ph
2a: Y = O
2b: Y = S
2c: Y = NMe
Ph
N
XX
YH
O
N
Ph
+
path A path B
N
YHYH
X
O
N
Ph
+
electrophile Ae
nucleophile An electrophile Be
nucleophile Bn
N
OHOH
OH
O
N
Ph
O
MeO OH
NH2 * HCl NH
OEtPh
+
3
4
5 6
 
Scheme 2.1. Retrosynthesis of the ligands 
 
For this concept, two possibilities exist. Either using the pyridine central unit as 
electrophile Ae and the oxazoline-nucleophile An (Path A) or just the other way 
around with nucleophilic pyridine Bn and oxazoline electrophile Be. The reactands 
can be derived from the same starting materials, reducing the number of steps. The 
pyridine components are uniformly made from commercially available diol 3 in only a 
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few steps in each case (vide infra). In analogy, the oxazoline building blocks are 
conveniently prepared from the same starting materials, namely enantiopure (S)-
serine methyl ester hydrochlorid (5) and imidate 6 which are easily accessible from 
the corresponding nitrile. This approach is very flexible and would in principle also 
allow the employment of other nucleo- or electrophilic building blocks because of the 
generality of the final Sn2-step. For the synthesis of ligands 2, a number of 
combinations was tried and the most promising reactions optimized. 
 
2.1 Synthesis of the Pyridine Units 
 
The central building blocks are best prepared from readily available 2,6-
bis(hydroxymethyl)pyridine (3) (Scheme 2.2).  
N
OHOH
3
N
ClCl
7
HCl
N
ClCl
8
SOCl2 (2.2 equivs.)
Et2O, 0°C to rt, 20 h
96%
sat. NaHCO3 (aq)
CH2Cl2, RT
93%
N
9
N
BrBr
10
NBS (2.15 equivs.)
AIBN (cat.), benzene
irradiation (250W)
10 h, reflux, 13%
 
Scheme 2.2. Synthesis of the electrophilic pyridine units 
 
Starting from diol 3, the electrophile 8 can be obtained within two steps by a known 
procedure.[1] Purification is advantageously achieved without chromatography by 
recrystallization. Alternatively, the even more reactive bromide 10 can be synthesized 
from inexpensive 2,6-lutidine (9) by radical bromination in low yield.[2] This material 
must be purified by column chromatography to separate side products consisting of 
isomeric and higher brominated species. Furthermore, because of its high 
electrophilicity, traces of 10 are highly lachrymatory what makes handling 
unpleasant. Therefore, instead of 10 the less reactive but more convenient 8 was 
employed. 
The synthesis of nucleophilic precursors is uniformly starting from diol 3 and 
involves mostly reported procedures (Scheme 2.3). 
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N
OHOH
3
N
ClCl
7
HCl
SOCl2 (2.2 equivs.)
Et2O, 0°C to rt, 20 h
96%
SeO2 (1.0 equiv.)
1,4-dioxane, reflux, 4 h
55%
N
OO
12
MeNH3Cl (2.4 equivs.)
K2CO3 (2.8 equivs.)
MeOH, 0°C to rt
CH2Cl2, 76%
N
NN
13Me Me
N
SHSH
11
N
HNNH
14 Me
NaBH4 (2.0 equivs.)
EtOH, rt, 16 h
67%
i)  thiourea (2.4 equivs.)
    EtOH, reflux, 20 min
ii) NaOH (5.5 equivs.)
    degassed H2O, argon
    reflux, 2h
32% (2 steps)
Me
 
Scheme 2.3. Synthesis of the pyridine based nucleophiles 
 
The preparation of dithiol 11 utilizes again hydrochloride 7. It is transformed to an 
intermediate bis(isothiourea) derivative which is cleaved to give 11 in low yield.[1] One 
reason for this is its sensitivity to oxidative degradation when exposed to air. The 
previously unknown secondary amine 14 is prepared by a reductive amination 
procedure, via the bis(aldehyde) 12[3] and diimine 13[4] in reasonable yield. Like 11, 
14 is air-sensitive, but stable under inert N2-atmosphere at 4°C. All steps involved in 
Scheme 2.3 do not require chromatographic purification, a big advantage for larger 
scales. 
 
2.2 Synthesis of the Oxazoline Units 
 
The oxazoline moiety is a very versatile functional group and its chemistry has a 
long standing history. In recent times, especially the group of Meyers[5] has 
developed a number of transformations and applications for this motive.  Therefore, 
the synthetic route involves well established chemistry and provides straightforward 
access to the desired precursors (Scheme 2.4). 
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OMe
O
N
Ph
OH
O
N
Ph
O
MeO OH
NH2 * HCl
NH
OEtPh+
4
5 6
1,2-dichloroethane
(1.0 equiv) (1.1 equivs)
reflux, 20h, 90%
O15
LiAlH4 (0.55 equivs.)
THF, -30°C to rt, 2.5 h
64%
(28.3 g)
 
Scheme 2.4. Synthesis of the nucleophilic oxazoline units 
 
The oxazoline ring is formed by condensation of optical pure (S)-serine derived 
methyl ester 5 and imidate 6, prepared by acid mediated Pinner-reaction[6] of 
benzonitrile and EtOH. The latter very versatile method tolerates in principle a big 
variety of acid-stable functional groups and allows the introduction of various 
substituents at the aromatic system (vide supra).[7] The building block 4 is obtained 
by a known procedure[8] via reduction of the crude ester 15. Instead of the reported 
reducing agent DIBAL-H, the less expensive LiAlH4 could be used without detectable 
racemization but with reduced yield (90% vs. 64%). This drawback is easily 
acceptable in the light of cost effectiveness. In case of need, 4 could also be 
converted to its enantiomeric form, by a known ring opening-ring closure sequence, 
also reported by Meyers.[8] This is a very useful feature because of the potential 
synthesis of both enantiomeric ligands 2 on the basis of the excellently available 
natural (S)-serine. The reduction could be scaled up without problems employing a 
maximum of 250 mmol of 15, yielding multigram amounts of 4. Unfortunately, the 
product has to be purified by column chromatography, but the separation is not very 
difficult and can be carried out in large batches without inconvenience. 
The synthesis of more nucleophilic oxazoline components was not followed, 
because of the potential serious problems associated with ring isomerization 
reactions (Scheme 2.5).  
 
 
 21
YH
O
N
Ph (Y = S, N-Alk)
OH
Y
N
Ph
 
Scheme 2.5. Potential stability problems of strongly nucleophilic oxazoline units 
 
The preparation of the oxazolines acting as electrophilic counterparts starts from 4, 
minimizing the necessary overall steps once again (Scheme 2.6). 
OH
O
N
Ph
4
OMs
O
N
Ph
16
OTs
O
N
Ph
17
Ts-Cl (1.1 equivs.)
NEt3 (2.2 equivs)
CHCl3, 0°C to rt, 20h
78%
Ms-Cl (1.05 equivs.)
NEt3 (1.1 equivs)
THF, -25°C, 30 min
96% (crude)
 
 
Scheme 2.6. Synthesis of electrophilic oxazoline building blocks. 
 
From a number of possible electrophilic reactants, only the sulfonic acid ester 
derived 16 and 17 were prepared. The tosylate 17 was synthesized by a standard 
procedure reported in the literature[9] yielding an air-stable solid which can be stored 
for an extended period of time without degradation at ambient temperature. The more 
reactive, oily mesyl derivative 16[10] can be used without purification in excellent yield 
but is not very stable and decomposes slowly upon standing in substance. Therefore, 
it is best used immediately after preparation. Chromatography as a means of 
purification can be avoided. 
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2.3 Assembly of the Ligands 
 
With a number of building blocks in hands, the final assembly proved to be 
straightforward (Scheme 2.7). 
N
OO
N
O O
N
PhPh
N
ClCl
OH
O
N
Ph
8 4
2a
+
(1.0 equiv.) (2.2 equivs.)
NaH (2.3 equivs.)
DMF, 0°C to rt, 20 h
88%
N
SHSH
OTs
O
N
Ph
11 17
+
(1.0 equiv.) (2.1 equivs.)
N
SS
N
O O
N
PhPh
2b
NaH (2.1 equivs.)
DMF, 0°C to rt, 20 h
72%
N
HNNH
OMs
O
N
Ph
14 16
+
(1.0 equiv.) (2.1 equivs.)
N
NN
N
O O
N
PhPh
2c
K2CO3 (4.0 equivs.)
CH3CN, reflux, 31 h
62%
 
Scheme 2.7. Modular construction of ligands 2  
 
The general approach for 2a and 2b involved the increase in nucleophilicity by 
deprotonation of 4 and 11. The attack at the electrophilic centers in 8 and 17 
proceeded smoothly and produced the final ligands in good yields. This strategy 
could not be used for the assembly of 2c. Because of the less nucleophilic character 
of the secondary amines in 14 compared to the alcoholate/thiolate-species, the 
reactive mesylate 16 had to be used instead of tosylate 17. After a number of trials, 
the conditions depicted yielded 2c in satisfactory amount. All ligands 2 have to be 
purified by column chromatography. 
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The NMR-spectra clearly show a C2-symmetrical structure of the ligands. Ligand 2a 
could also be crystallized and examined by X-ray analysis (Figure 2.1). The structural 
characteristics exhibit no unusual features. 
 
Figure 2.1. Crystal structure of ligand 2a (hydrogens only shown at the stereogenic centers). Crystal 
data for 2a: C27H27N3O4 (457.52); colorless rod (0.58mm*0.40mm*0.12mm); monoclinic (P21); 
a=4.8350(3) Å, b=11.3117(7) Å, c=21.9468(11) Å, β=92.859(6); V=1198.82(12) Å3; Z=2; ρ=1.268 
g/cm3; µ=1.268 mm-1; T=173(1) K; MoKα(λ=0.71073 Å); 4.13°<θ<25.87°; 11794 reflections collected, 
4534 independent, 4243 in refinement (I ≥ 2σ(I)); R1=0.0351, wR2=0.0891, R1(all data)=0.0373, 
wR2(all data)=0.0906; absolute structure param.=0.1(7). 
 
In conclusion, the synthesis of the desired ligands 2 proves to be straightforward 
and very flexible towards structural variations. Furthermore, the number of 
chromatographic purifications can be limited to a minimum of four (4 and 2a-c) 
making a preparation even on larger scale seem feasible. The presented strategy 
should also allow the facile introduction of additional functionalities for secondary 
interactions (vide supra). 
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3.  Complex Synthesis 
 
 
The general strategy for the investigation of the coordination properties of ligands 2 
was determined by the following requirements: 
 
● Preparation of mononuclear complexes 
 Because of the high denticity of five for 2, only weakly coordinating anions (like 
ClO4-, OTf-, BF4-, ...) enable coordination of all ligand donors to one metal 
center in the range of the possible coordination numbers (especially 5,6,7...).  
● Systematic variability of certain properties  
 Especially the investigation of the influence of ionic radii and number of valence 
electrons under otherwise identical conditions would be desirable. 
● Relative substitution stability 
 The ligands should bind rather strong to the metal center to suppress 
complicating exchange processes.  
 
Taking these preferences into account, first-row late transition metal(II) triflates and 
perchlorates seemed to be ideal candidates also because of several other 
characteristics: 
 
● Commercial availability of all perchlorates [MII(H2O)6](ClO4)2  (M = Mn-Zn), 
likewise for a number of anhydrous metal triflates (e.g. Cu(OTf)2, Zn(OTf)2). 
● The relevance of these metals for a large number of catalytic processes, both in 
nature and in synthetic systems. 
 
3.1 Perchlorate Complexes of First-Row Transition Metals 
 
In spite of their potentially explosive nature, the perchlorate complexes turned out to 
be the most suitable series for our investigation. This was mainly due to the 
operational ease of isolation and purification. After a few unsuccessful attempts with 
various solvent mixtures, the following protocol was found to be suitable. Dissolving 
equimolar amounts of the corresponding metal precursor [MII(H2O)6](ClO4)2  and 
ligand 2 separately under nitrogen atmosphere in dry THF and combining the two 
solutions resulted in precipitates of the desired complexes (Scheme 3.1). This 
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procedure allowed the facile separation of excess ligand or metal salt by simply 
washing the products with THF. Only in the case of MnII and ligand 2b, no precipitate 
was observed and therefore this preparation was abandoned. 2c was only used in 
combination with ZnII due to the lack of sufficient amounts of this ligand at the 
beginning. Zinc in this case was chosen because of the diamagnetic behavior of the 
complexes, making NMR-spectroscopy possible (vide infra). 
 
N
OO
N
O O
N
PhPh
2a
N
SS
N
O O
N
PhPh
2b
[M(H2O)6](ClO4)2
(1.0 equiv.)
THF, rt
[M(H2O)6](ClO4)2
(1.0 equiv.)
THF, rt
N
NN
N
O O
N
PhPh
2c
[Zn(H2O)6](ClO4)2
(1.0 equiv.)
THF, rt
[Mn(2a)(H2O)2](ClO4)2 * THF   (77%)
[Fe(2a)(H2O)2](ClO4)2 * THF    (43%)
[Co(2a)](ClO4)2                        (94%)
[Ni(2a)](ClO4)2 *H2O * THF      (90%)
[Cu(2a)](ClO4)2 *H2O * THF     (91%)
[Zn(2a)](ClO4)2                             (86%)
[Fe(2b)(H2O)](ClO4)2 * 2 H2O    (46%)
[Co(2b)(THF)](ClO4)2 * H2O      (91%)
[Ni(2b)](ClO4)2 *2 H2O               (90%)
[Cu(2b)](ClO4)2 *H2O                (82%)
[Zn(2b)](ClO4)2  * H2O                   (80%)
[Zn(2c)](ClO4)2  *CH3CN * H2O    (60%)
 
Scheme 3.1. Synthesis of first-row transition metal perchlorate complexes 
 
After simply drying the solids in vacuo, analytical pure material was obtained. All of 
the shown complexes were characterized by mass spectrometry to be mononuclear. 
Elemental analysis gave stoichiometries consistent with the formulae given above. In 
some cases, additional ligands like H2O or THF could be assigned to the inner 
 27
coordination sphere of the metal on the basis of either crystal structures or predicted 
coordination geometries in solution (vide infra). All complexes are relative air stable 
solids. They are soluble in polar solvents like MeOH or CH3CN and dissolve only very 
poorly in less polar media like CH2Cl2, EtOAc, ethers or hydrocarbons. This makes 
the perchlorates not ideally suited for Lewis-acid catalytic applications, because most 
of them desire solvents of the latter kind. In principle, anion exchange could be 
beneficial for the solubility problem. For the structural investigations conducted in this 
work, it does not constitute a problem.  
 
3.2 Triflate Complexes of First-Row Transition Metals 
 
The triflate anion has a few advantages compared with perchlorate. First of all, the 
complexes are not potentially explosive in combination with organic substances like 
the latter. In addition, some metal triflates are commercially available in anhydrous 
form, making them one of the metal precursors of choice in water sensitive catalytic 
processes. Last but not least, the solubility is often enhanced in comparison with 
perchlorates. In our case, this was not advantageous because the triflate complexes 
in most instances did not precipate and could not be obtained in analytically pure 
form by other means. On the other hand, only copper(II)- and zinc(II)-triflate can be 
purchased from commercial suppliers.  
Because of the relevance to dioxygen activation (see introduction), iron(II) and 
cobalt(II) drew our attention. For this purpose, it was decided to synthesize these two 
metal triflates in anhydrous form by a procedure reported by Hagen for Fe(OTf)2*2 
CH3CN.[1] Unfortunately, even after multiple attempts it was not possible to reproduce 
the protocol described. The possibility to prepare the corresponding Co(II)-triflate was 
also mentioned in this article. In contrast to Fe(II), the synthesis of Co(OTf)*2 CH3CN 
was no problem at all (Scheme 3.2). 
 
Co-dust
anhyd. HOTf (2.1 equivs.)
CH3CN, reflux, 2 h, 81%
Co(OTf)2*2 CH3CN
 
Scheme 3.2. Preparation of anhydrous Co(II)-triflate 
 
With the triflates of divalent cobalt, copper and zinc in hand, a number of 
complexation attempts were conducted. Only in the case of cobalt a complex could 
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be obtained with ligand 2b in analytically pure form (Scheme 3.3) following the 
protocol for the precipitation of the perchlorates (see section 3.1).  
 
Co(OTf)*2 CH3CN
(1.0 equiv.)
THF, rt, 3 h, 68%
[Co(2b)(THF)](OTf)2
N
SS
N
O O
N
PhPh
2b
 
Scheme 3.3. Preparation of the CoII-complex with 2b by precipitation 
 
Nevertheless, a few small single crystals out of these trials could be separated from 
the reaction mixtures and the solid state structures studied (vide infra). 
 
3.3 Miscellaneous Complexes 
 
To further test the complexation behavior of ligands 2, a number of other metals 
were used for a number of different purposes.  Since most first-row transition metals 
exhibit paramagnetic behavior and can therefore provide no NMR-information in this 
respect, the first approach was to synthesize a few additional diamagnetic 
complexes. In principle, this can achieved with metals of even-numbered electron 
configuration. Essentially, two promising classes were considered: d10-species (CuI 
and CdII) and low-spin d6-centers (RuII). 
The synthesis of the cadmium(II) complexes was straightforward by applying the 
precipitation strategy for the first-row metals (Scheme 3.4, see also section 3.1).  
 
N
YY
N
O O
N
PhPh
2a (Y = O)
2b (Y = S)
[Cd(H2O)6](ClO4)2
(1.0 equiv.)
THF, rt
[Cd(2a)(?)](ClO4)2         (>75%)
[Cd(2b)](ClO4)2 * THF    (95%)
 
Scheme 3.4. Preparation of the CdII-perchlorate complexes 
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In the case of the complex with ligand 2a, it was not possible to get a sufficient 
elemental analysis. Nevertheless, the conversion was almost quantitative indicated 
by a simple mass balance. 
Starting from the copper(II) perchlorates, reduction with NaBH4 yielded yellow 
compounds which were unambiguously identified as CuI-species by mass 
spectrometry (with 2b) and their diamagnetic behavior (NMR) (Scheme 3.5). 
 
[CuII(2a)](ClO4)2 *H2O * THF
[CuII(2b)](ClO4)2 *H2O
NaBH4 (1.13 equivs.)
NaBH4 (1.02 equivs.)
degas. CH3CN/MeOH
rt, 18 h
degas. CH3CN/MeOH
rt, 1 h
[CuI(2a)(?)](ClO4)2
[CuI(2b)(?)](ClO4)2
 
Scheme 3.5. Reductive synthesis of the copper(I) complexes 
 
The two compounds had to be synthesized under rigorous exclusion of atmospheric 
dioxygen and were not isolated in substance for this reason. Short exposure of the 
NMR-samples to air yielded paramagnetic spectra after several hours, probably 
originating from reoxidized copper ions. This observation is very interesting because 
of the relevance of copper(I) complexes for the activation of dioxygen in nature,[2] like 
in the enzyme galactose oxidase or the O2-transport protein hemocyanin in the blue 
blood of mollusks and arthropods. Because of the orientation of this work towards 
structure elucidation rather than reactivity investigation this aspect was not followed 
further. 
The synthesis of a diamagnetic ruthenium(II) complex was tried with one of the 
most facile RuII-precursors, [RuCl2(benzene)]2.[3] Refluxing with ligand 2b in an 
ethanolic solution and workup yielded a mixture of two species (Scheme 3.6). 
 
[RuCl2(benzene)]2
1. 2b (2.0 equivs.)
    EtOH, relux, 10 h
2. CH2Cl2
[Ru(2b)(Cl)]Cl [Ru(2b)(?)]Cl+
(3:7)
(quantitative conversion)
 
Scheme 3.6. Preparation of diamagnetic RuII-complexes 
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Unfortunately, it was not possible to separate the two complexes for a complete 
characterization. Nevertheless, it was possible to predict the nature of the two 
species on the basis of different analytical methods (vide infra).  
The second approach for the complexation involved the testing of metals other than 
transition metals. As a representative of a main group element, magnesium was 
chosen for the availability of both Mg(ClO4)2 and Mg(OTf)2. The preparation started 
from the perchlorate (Scheme 3.7). 
 
N
OO
N
O O
N
PhPh 2a
Mg(ClO4)2
(1.0 equiv.)
THF, rt, 70%
[Mg(2a)(H2O)2](ClO4)2
 
Scheme 3.7. Synthesis of the MgII-perchlorate complex with 2a 
 
Another class of catalysis-relevant metals are the lanthanides. To see if ligands 2 
could accommodate these rather large atoms, the choice fell on ytterbium. It is the 
second smallest representative in the row of the trivalent ions because of the 
lanthanide contraction and is commercially available (Yb(OTf)3). The synthesis was 
straightforward (Scheme 3.8). 
 
N
OO
N
O O
N
PhPh 2a
Yb(OTf)3
(1.0 equiv.)
THF, rt 8 h
 reflux 12 h, 71%
[Yb(2a)(H2O)(OTf)](OTf)2
 
Scheme 3.8. An example for a lanthanide complex with YbIII 
 
The assigment of additional ligands to the inner coordination sphere was made on 
the basis of mass spectrometry. 
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4.  Structural Investigations 
 
4.1 General Considerations 
 
This part constitutes the core of this thesis. Before the actual structure 
determination will be developed, a few general thoughts on this matter should be 
dealt with. The issue of central importance upon metal complexation with ligands 2 is 
the resulting stereochemistry. A great variety of possibilities can arise depending on 
different coordination geometries. However, there are a few invariable features in 
ligand arrangement because of the special geometry of 2. The most important 
characteristic is the necessity for the three middle donor groups (red in Figure 4.1) of 
the ligands to coordinate in a meridional fashion. 
M
N
YY
O
N
Ph
MN
Y
Y
N
N
M
Y
Y
N
O
Ph
N N
YY
2
N
N
N
N
trigonal-bipyramidal
octahedral pentagonal-bipyramidal
N
N
M
Y
Y
N
square-pyramidal
 
Figure 4.1. Some examples for different geometries: middle three donors (red) always meridional 
 
This requirement is mainly due to the planarity of the pyridine ring forcing the close-
by attached atoms to adopt a conformation only slightly deviating from this plane. 
With increasing distance from the pyridine, the oxazoline arms gain enough flexibility 
to take a position above or below, thereby determining the configuration at the metal 
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center. The octahedral geometry shall serve as illustration for these possibilities 
(Figure 4.2).  
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Ph
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Figure 4.2.  Possible isomers with ligands 2 in octahedral metal complexes 
  
Basically, there are two principal arrangements for the two oxazoline arms. Either 
they can coordinate both out of the pyridine plane in opposite half spaces (∆2 or Λ2) 
adopting positions trans to each other in the case of the octahedron. Alternatively, 
one arm takes a position in the plane and the other adopts an apical position (Λ∆ or 
∆Λ), resulting in a cis-arrangement of the oxazoline donors. These two types exist 
both as a pair of enantiomers. Due to the chirality of the ligands in our case, the two 
forms of these pairs are not enantiomeric but diastereomeric to each other.  
The generation of the new stereogenic metal center in a broader sense goes hand 
in hand with the deviation from the plane, spanned by the three middle donors. 
Therefore, analoguous stereoisomeric relations hold true for other coordination 
geometries (Figure 4.1). The pentagonal bipyramide constitutes a special case. If all 
ligand donors coordinate in one planar arrangement, the resulting metal configuration 
should be inherently achiral. With ligands 2 (as will be seen later) the deviation from 
this pentagonal plane by the ligand backbone is big enough to clearly contribute to a 
chiral helical structure. 
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4.2 Solid State Structures 
 
The elucidation of structural information in coordination chemistry is often not an 
easy task. Especially in transition-metal complexes the application of NMR-
spectroscopy, one of the most powerful tools for structure determination, is often 
complicated by paramagnetic properties. Therefore, in many cases only methods like 
IR- or UV-spectroscopy can be applied, often only of significance in combination with 
other pieces of information or by comparison with known precedences. Due to these 
problems the commonly used approach relies on the most direct method for structure 
determination, single crystal X-ray analysis. In our case, it was also possible to 
perform a number of crystal structure analyses of the complexes synthesized. In this 
section only the basic structural parameters will be discussed. For a comprehensive 
comparison of all structures in the context of related subjects see Section 6. More 
detailed information on bond lengths and angles can be found in the appendix or by 
retrieving the corresponding cif-file from the Cambridge Crystallographic Data Centre 
(http://www.ccdc.cam.ac.uk).  
 
● [FeII(2a)(H2O)2](ClO4)2 *THF 
The structure of this iron(II) complex shows an unexpected pentagonal-bipyramidal 
geometry (Figure 4.3, Table 4.1). 
                   
Figure 4.3. Crystal structure of the cation of [FeII(2a)(H2O)2](ClO4)2 *THF (hydrogens only shown at 
the stereogenic carbon atoms of ligand 2a and for the H2O molecules) 
 
The C2-symmetry of the ligand is retained in the complex. The perchlorate 
counterions are non-coordinating. All five donor atoms of 2a coordinate in the 
pentagonal plane and show bond lengths to the iron center in the usual range (Fe-N: 
2.23-2.34Å, Fe-O: 2.33-2.34Å). The water molecules bind to the metal at the two 
axial positions and have shorter Fe-O-bond lengths (2.11-2.15Å) compared to the 
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ether-oxygen donors of the ligand as can be expected. Because of the phenyl rings 
deviating significantly from the pentagonal plane and having one single preferred 
orientation, the complex can be assigned a stereogenic metal center with Λ2-
configuration. Alternatively this behavior can be described as an exclusive right-
handed helical arrangement of the ligand. 
 
Table 4.1. Crystal data for iron-, cobalt- and cadmium-complexes of ligands 2 
 
[Fe(2a)(H2O)2](ClO4)2 
*THF  
 
[Co(2b)(THF)](OTf)2  
 
CCDC 216870 
[Co(2c)(H2O)](OTf)2  
  
 
{[Cd(2b)(ClO4)](ClO4)}3 
*CH3CN 
formula C31H39Cl2FeN3O15  C33H35CoF6N3O9S4 C31H35CoF6N5O9S2 C83H84Cd3Cl6N10O30S6 
crystal app. colorless stick pink prism pink block colorless prism 
mol. weight 820.40 918.81 858.69 2443.95 
crystal system orthorhombic monoclinic monoclinic monoclinic 
space group P212121 P21 P21 P21 
a [Å] 8.2616(7) 11.481(3) 9.784(2) 9.6544(8) 
b [Å] 14.0004(10) 8.809(2) 19.746(4) 17.8800(9) 
c [Å] 30.790(2) 18.976(4) 9.811(2) 27.549(2) 
α [°] 90 90 90 90 
β [°] 90 105.688(5) 105.954(4) 97.008(10) 
γ [°] 90 90 90 90 
volume [Å 3] 3561.3(5) 1847.7(7) 1822.4(6) 4720.0(6) 
Z 4 2 2 2 
ρ [g cm-1] 1.530 1.652 1.565 1.720 
µ [mm-1] 0.648 0.779 0.675 1.058 
crystal size [mm] 0.34*0.08*0.06 0.28*0.18*0.10 0.58*0.24*0.20 0.16*0.16*0.10 
temperature [K] 173(1) 100(2) 100(2) 173(1) 
radiation [Å] MoKα ( *λ = 0.71073) MoKα ( *λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
θ max [°] 1.97 < θ < 25.81 2.23 < θ < 25.00 2.06 < θ < 26.00 1.88 < θ < 25.87 
measured  
reflections 
30644 10392 12020 33866 
independent  
reflections 
6802 5661 6746 17358 
reflections 
in refinement 
4743, I ≥ 2σ(I) 5392, I ≥ 2σ(I) 6643, I ≥ 2σ(I) 13828, I ≥ 2σ(I) 
R[a] 0.0443 0.0710 0.0317 0.0397 
wR2[b] 0.0884 0.1838 0.0800 0.0865 
R[a] (all data) 0.0723 0.0733 0.0321 0.0534 
wR2 (all data) 0.0963 0.1866 0.0803 0.0913 
absolute  
structure param. 
– 0.01(2) 0.05(2) 0.008(10) – 0.023(17) 
[a] R factor definition: R = Σ (||F0| – |Fc||) / Σ |F0|. [b] SHELX-97 wR2 factor definition: wR2 = [Σ w(F02 – Fc2)2 / Σ 
w(F04)]1/2. Weighting scheme: w = 1 / [σ2(F0)2 + (np)2], p = [F02 + 2 Fc2] / 3. 
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Table 4.2. Crystal data for zinc-complexes of ligands 2 
 
[Zn(2a)](ClO4)2  
 
CCDC 236254 
[Zn(2a)](OTf)2  
* CH2Cl2 
[Zn(2b)](ClO4)2  
*H2O  
CCDC 236253 
[Zn(2c)](ClO4)2   
*CH3CN * H2O  
 
formula C27H27Cl2N3O12Zn C30H29Cl2F6N3O10S2Zn C27H29Cl2N3O11S2Zn C31H36Cl2N6O10Zn 
crystal app. colorless prism colorless stick colorless prism colorless prism 
mol. weight 721.81 905.99 771.96 778.95 
crystal system monoclinic orthorhombic orthorhombic orthorhombic 
space group P21 P212121 C2221 C2221 
a [Å] 8.8261(8) 8.7347(6) 14.5688(9) 11.9149(8) 
b [Å] 9.9900(7) 15.2145(10) 11.4522(10) 14.3568(9) 
c [Å] 16.8095(16) 26.9055(19) 18.3976(12) 19.8710(18) 
α [°] 90 90 90 90 
β [°] 99.692(11) 90 90 90 
γ [°] 90 90 90 90 
volume [Å 3] 1461.0(2) 3575.6(4) 3069.5(4) 3399.1(4) 
Z 2 4 4 4 
ρ [g cm-1] 1.641 1.683 1.666 1.542 
µ [mm-1] 1.094 1.044 1.176 0.946 
crystal size [mm] 0.22*0.20*0.12 0.72*0.24*0.18 0.20*0.18*0.10 0.46*0.44*0.22 
temperature [K] 173(1) 173(1) 173(1) 173(1) 
radiation [Å] MoKα ( *λ = 0.71073) MoKα ( *λ = 0.71073) MoKα (λ = 0.71073) MoKα (λ = 0.71073) 
θ max [°] 2.34 < θ < 25.91 2.45 < θ < 25.85 2.26 < θ < 25.86 2.45 < θ < 25.86 
measured  
reflections 
20388 30057 10957 12740 
independent  
reflections 
5624 6882 2964 3279 
reflections 
in refinement 
4833, I ≥ 2σ(I) 6405, I ≥ 2σ(I) 2461, I ≥ 2σ(I) 3173, I ≥ 2σ(I) 
R[a] 0.0276 0.0377 0.0337 0.0351 
wR2[b] 0.0561 0.0999 0.0703 0.0968 
R[a] (all data) 0.0362 0.0411 0.0449 0.0359 
wR2 (all data) 0.0580 0.1022 0.0731 0.0974 
absolute  
structure param. 
– 0.015(8) 0.000(10) – 0.001(16) – 0.002(13) 
[a] R factor definition: R = Σ (||F0| – |Fc||) / Σ |F0|. [b] SHELX-97 wR2 factor definition: wR2 = [Σ w(F02 – Fc2)2 / Σ 
w(F04)]1/2. Weighting scheme: w = 1 / [σ2(F0)2 + (np)2], p = [F02 + 2 Fc2] / 3. 
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● [CoII(2b)(THF)](OTf)2 
As expected the structure of the cobalt(II) complex exhibits a normal, only slightly 
distorted octahedral geometry (Figure 4.4, Table 4.1). 
                       
Figure 4.4. Crystal structure of the cation of [CoII(2b)(THF)](OTf)2 (CCDC No. 216870) (hydrogens 
only shown at the stereogenic carbon atoms of ligand 2b) 
 
Once more the symmetry of the ligand is conserved upon complexation yielding a 
∆2-configured species. THF is coordinating as the sixth ligand in trans-position to the 
pyridine ring, the triflate anions are non-coordinating. The bond lenghts are not 
unusual (Co-N: 2.11-2.14Å, Co-S: 2.46-2.48Å, Co-O: 2.07Å). The angles X-Co-X (X= 
O, S, N) vary slightly from an ideal right angle (80.6°-98.6°) or 180° (165.0°-179.7°) 
respectively. The two phenyl rings point away from the cobalt center and provide a 
rather tight chiral pocket, effectively shielding two opposite quadrants of the 
accessible front space of the complex. 
 
● [CoII(2c)(H2O)](OTf)2 
Like in the preceeding cobalt species with thioether ligand 2b, the Co(II)-complex 
with 2c shows octahedral, almost C2-symmetrical geometry (Figure 4.5, Table 4.1). 
 
                       
Figure 4.5. Crystal structure of the cation of [CoII(2c)(H2O)](OTf)2 (hydrogens only shown at the 
stereogenic carbon atoms of ligand 2c) 
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The distortion of this ∆2-configured complex from a regular octahedron increases in 
comparison with [CoII(2b)(THF)]2+. The angles X-Co-X (X = O, N) vary between 
77.5°-107.8° (ideally 90°) and 154.7°-176.8° (ideally 180°). The bond lenghts are 
similar (Co-N: 2.07-2.26Å, Co-O: 2.03Å). Besides these details the overall structures 
of the two cobalt complexes of 2a and 2b are very similar and show the same ∆2 
selectivity. 
 
● [ZnII(2a)](ClO4)2 and [ZnII(2a)](OTf)2*CH2Cl2 
The zinc complexes with ligand 2a show distorted trigonal-bipyramidal geometry 
with almost C2-symmetry, irrespective of the nature of the counterion (ClO4, OTf) 
(Figures 4.6 and 4.7, Table 4.2). Because they differ only marginally from one 
another the perchlorate complex will be solely discussed here. 
 
    
Figure 4.6. Crystal structure of the cation of [ZnII(2a)](ClO4)2 (CCDC No. 236254) (hydrogens only 
shown at the stereogenic carbon atoms of ligand 2a) 
 
 
Figure 4.7. Crystal structure of the cation of [ZnII(2a)](OTf)2*CH2Cl2 (hydrogens only shown at the 
stereogenic carbon atoms of ligand 2a) 
 
The trigonal plane is spanned by the zinc atom and the three nitrogen donors of the 
pyridine and the oxazolines. They have almost equal Zn-N bond lengths (1.95-2.03Å) 
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and comprise angles N-Zn-N between 113.7° and 129.6° (ideally 120°). The axial 
positions of the ether oxygens (Zn-O: 2.22-2.28Å) are tilted from an ideal position 
perpendicular to the trigonal plane towards the pyridine moiety (e.g. Npyridine-Zn-O1 = 
76.9° or Npyridine-Zn-O2 = 76.1°). Surprisingly, the complex favors to adopt a Λ2-, 
rather than the expected ∆2- configuration. This results in the stacking of the phenyl 
rings in close proximity to the rest of the ligand backbone, initially thought to exert a 
strong steric strain upon the complex in comparison with the ∆2-case where the 
aromatic rings point away from the metal center. In consequence of this observation, 
steric arguments alone can not account for the stereoselectivity (vide infra). 
 
● [ZnII(2b)](ClO4)2*H2O 
Like the preceeding complexes the combination of ZnII with ligand 2b yields 
trigonal-bipyramidal species (Figure 4.8, Table 4.2).  
 
                
Figure 4.8. Crystal structure of the cation of [ZnII(2b)](ClO4)2*H2O (CCDC No. 236253) (hydrogens 
only shown at the stereogenic carbon atoms of ligand 2b) 
 
This time the complex shows ideal C2-symmetry but astonishingly with the opposite 
configuration ∆2, where the phenyl rings are directed away from the center. The 
degree of distortion from the ideal trigonal-bipyramidal geometry is similar to the 
complexes with 2a. Zn-N bond lengths (Zn-N: 1.98-2.10Å) are in the same range. 
Angular deviation is a little larger (N-Zn-N: 100.0°-139.8°) whereas the tilt of the axial 
thioether donors (Zn-S: 2.53Å) is only small (e.g. Npyridine-Zn-S = 84.4°) in comparison 
with the ideal value of 90°. The main reason for the difference between the structures 
of the zinc complexes with 2a and 2b is the Cbenzylic-Y (Y = O, S) bond length (C-O: 
1.44Å vs. C-S: 1.81Å), probably also accounting for the complete reversal of 
stereoselectivity from Λ2 to ∆2. 
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● [ZnII(2c)](ClO4)2*CH3CN*H2O 
The structure of this complex resembles the corresponding species with ligand 2a 
(Figure 4.9, Table 4.2).  
 
                
Figure 4.9. Crystal structure of the cation of [ZnII(2c)](ClO4)2*CH3CN*H2O (hydrogens only shown at 
the stereogenic carbon atoms of ligand 2c) 
 
These complexes share the trigonal-bipyramidal geometry, the idealized C2-
symmetry and most interestingly the stereoselectivity for Λ2. The donors lying in the 
trigonal plane (Npyridine, Noxazoline) have similar Zn-N bond lengths compared to the 
other zinc complexes (2.03-2.11Å) and comprise angles close to the ideal value of 
120° (N-Zn-N: 119.0°-122.0°). In contrast to this the tertiary amine donor nitrogens 
are a little further away from the zinc center (2.29Å) and are tilted with respect to the 
trigonal plane (e.g. Namine-Zn-Npyridine = 75.4°). Probably the similarity in bond lengths 
Cbenzylic-Y (Y = O, N) induce the same configurational preference for Λ2 (C-O: 1.44Å 
vs. C-N: 1.48Å) (vide supra). 
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● {[CdII(2b)(ClO4)](ClO4)}3*CH3CN 
The cadmium complex with 2b is different from all other structures seen before. 
This is the only case where one of the weakly coordinating anions (perchorate) is 
bound to the metal center (Figure 4.10, Table 4.1).  
 
        
Figure 4.10. Crystal structure of one of the three unique cations of {[CdII(2b)(ClO4)](ClO4)}3*CH3CN  
(hydrogens only shown at the stereogenic carbon atoms of ligand 2b) 
 
In the unit cell three very similar unique complexes are present differing only 
marginally from one another. Figure 4.10 shows only one of these unique cations. 
The complexes exhibit a strong distortion from C2-symmetry and all show unexpected 
Λ2-configured octahedral coordination geometry. The bond lengths are rather long 
(Cd-N: 2.28-2.42Å, Cd-S: 2.65-2.68Å, Cd-O: 2.40-2.61Å). The strong distortion 
probably expresses the problem of ligand 2b to accommodate the rather large 
second-row transition metal cadmium (ionic radius for six coordinate CdII: 0.95Å). 
Presumably, this is also the reason why the otherwise disfavored Λ2-configuration 
(see Co-complexes) is the only observed stereoisomer in the solid state. 
 
In conclusion, all solid state structures of mononuclear complexes of ligands 2 
retain idealized C2-symmetry, though sometimes slightly distorted. A number of 
coordination geometries are realized comprising coordination numbers between five 
and seven. In almost every case a single, but not uniformly preferred metal 
configuration is observed in the crystal. The selectivity can not be easily explained by 
steric arguments as initially thought. The specific properties of the individual ligands 
will be discussed in the context of the solution state investigations.  
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4.3 NMR-Spectroscopy 
 
Nuclear magnetic resonance (NMR) spectroscopy is without doubt one of the most 
powerful tools for structural analysis. As mentioned before, the best results can be 
obtained for compounds with only paired electron spins. In this case, the subjects of 
investigation were the diamagnetic complexes of CuI, ZnII, CdII, RuII. All other species 
showed paramagnetic behavior. To rule out the existence of slow isomerization 
reactions in solution, the samples were measured twice with an interval of at least 
two days. The spectra were identical in every case showing the stability of the 
complexes towards degradation in solution. 
Before the analysis of the complexes it is useful to briefly have a look at the specific 
features of ligands 2 (Figure 4.11). 
 
N
YY
N
O O
N
2a: Y = O
2b: Y = S
2c: Y = NMe
HB
HC
HD
HD
HC
HA
HA HA
HA
 
Figure 4.11. Domains of interest concerning NMR-spectroscopy in ligands 2 
 
There are a number of very diagnostic 1H-signals indicating C2-symmetry both in 
the free ligand as well as upon complexation. The spectra of 2a-c are very similar. 
Therefore, only the ones for 2a will be depicted (Figure 4.12). For details concerning 
2b-c see the appendix.  In the aromatic region especially the signal of the protons HB 
(triplet) and HA (multiplet) are useful because of the separation from the other 
aromatic peaks. Due to the flexibility of the ligand arms the benzylic protons HC/HD 
show only one (broad) signal despite actually being diastereotopic. The 13C-NMR 
spectrum shows the C2-symmetry of 2a (Figure 4.13). 
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Figure 4.12. 1H-NMR (300MHz, CD3CN) spectrum of 2a clearly showing distinguished signals 
16
4.
90
70
15
8.
96
82
13
8.
30
00
13
2.
42
96
12
9.
54
82
12
9.
02
07
12
1.
05
03
74
.9
17
9
73
.5
01
6
71
.0
01
1
67
.6
41
0
(ppm)
0102030405060708090100110120130140150160170180190200
 
Figure 4.13. 13C-NMR (75.5MHz, CD3CN) spectrum showing the C2-symmetry of 2a 
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Upon complexation most of the proton signals are shifted to lower field. Normally HB 
is the best indicator because of the strong shift to about 8.0 ppm. Because of the 
reduced conformational flexibility in the complexes, the benzylic protons HC/D split in 
a few cases to give two doublets with geminal coupling (J > 15Hz). These signals can 
sometimes not be resolved from other overlapping peak patterns. The 13C-NMR 
spectra are very good indicators for the overall symmetry of the complexes. Once 
more, most of the peaks are shifted to higher ppm-values. Especially the peaks for 
the quarternary carbon atom C2 in the oxazoline ring is very diagnostic. It can be 
assigned most unambiguously and secondly implies the binding of the oxazolines if 
shifted. 
Table 4.4 surveys some characteristics of the isoelectronic CuI- and ZnII-complexes 
along with the ones for CdII, the heavier homologue of the latter, and RuII. 
 
Complex Solv. Number 
of 
species 
δ(HB)comp 
 
[ppm] 
δ(HB)
 comp - 
δ(HB)free 
[ppm] 
δ (C2ox)comp  
 
 [ppm] 
δ (C2ox)comp - 
δ (C2ox)free  
 [ppm] 
C2-
Sym. 
[CuI(2a)(?)](ClO4) 
* ? 
CDCl3 1 7.73 + 0.08 166.1 + 1.1 ! 
[CuI(2b)(?)](ClO4) 
* ? 
CDCl3 1 7.71 + 0.11 165.5 + 1.0 ! 
[ZnII(2a)](ClO4)2 
 
CD3CN 1 8.12 + 0.43 175.4 + 10.5 ! 
[ZnII(2b)](ClO4)2  
* H2O 
CD3CN 1 8.08 + 0.44 172.7 + 8.1 ! 
[ZnII(2c)](ClO4)2  
*CH3CN * H2O 
CD3CN ≥ 2 - - - - ? 
[CdII(2a)(?)](ClO4)2  
 
CD3CN 1 8.02 + 0.33 170.5 + 5.6 ! 
[CdII(2b)](ClO4)2  
* THF 
CD3CN ? broad - broad - ? 
 
Table 4.4. Comparison of the CuI-, ZnII- and CdII-complexes with 2a-c (for the complete spectra see 
the appendix) 
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As example the spectra of [Zn(2a)](ClO4)2 are shown in Figure 4.14.  
1.
02
33
5.
99
29
3.
97
96
2.
00
00
4.
07
40
1.
92
96
5.
98
71
1.
91
39
In
te
gr
al
(ppm)
0.01.02.03.04.05.06.07.08.09.010.0
 
17
5.
37
78
15
5.
28
59
14
3.
67
21
13
5.
84
83
13
0.
39
80
13
0.
25
14
12
4.
78
16
12
4.
14
67
73
.7
26
2
73
.1
30
4
71
.0
49
9
64
.6
32
6
(ppm)
0102030405060708090100110120130140150160170180190200
 
Figure 4.14. 1H-NMR (300 MHz, CD3CN) and 13C-NMR (75.5 MHz, CD3CN) spectra of [Zn(2a)](ClO4)2 
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As can be seen from Table 4.4, the complexation behavior of ligands 2a and 2b 
with CuI and ZnII is very similar. In these cases only one single species can be 
observed, indicating completely stereoselective complex formation. Both ligands 
show almost identical shifts for certain signals (HB and C2 of the oxazoline ring) 
indicating a very close structural relationship. Metals with d10 electron configuration 
are relative indifferent towards special coordination geometries because of the lack of 
ligand field stabilization energy. With respect to zinc(II), a trigonal-bipyramidal 
arrangement like in the solid state is very likely. Concerning the copper(I) species 
nothing is known about the crystal structure. Therefore, the assignment to one 
specific coordination geometry is highly speculative. Nevertheless, a trigonal-
bipyramidal geometry in analogy to the isoelectronic ZnII-complexes is presumably 
the best guess, also supported by the isostructural relationsship between CuII and 
ZnII as indicated by CD-spectroscopy (vide infra). 
The combination of zinc(II) with ligand 2c yields spectra with more than one 
species, in contrast to the solid state where only one complex could be observed. 
Their nature could not be clarified. This behavior has to be attributed to the additional 
methyl groups at the connecting tertiary amines exerting a strong steric strain on the 
ligand backbone upon complexation. This strain which has the biggest effect in the 
very crowded trigonal-bipyramide (see solid state) is probably relieved in solution by 
dissociation of one ligand arm from the metal center.  
In the case of CdII only the complex with 2a exhibits well-defined behavior. With 2b 
very broad proton spectra are obtained, indicating exchange processes and/or major 
configurational changes in solution. This is one more hint that 2b is not a suitable 
ligand for large metals like cadmium, as could also be seen in the strong distortion of 
the crystal structure of [Cd(2b)(ClO)4]+. Ligand 2a has the much smaller donor atom 
oxygen instead of sulfur and very probably adopts a pentagonal-bipyramidal 
geometry (see CD-spectroscopy) which apparently has the ability to accommodate 
much larger cations than 2b. 
Special cases are the very probably octahedral RuII-complexes with 2b. NMR 
clearly shows two independent C2-symmetrical species (ratio 7:3) as could be shown 
by complete correlation of the spectra. Therefore, only ∆2 or Λ2 are possible 
configurations. This problem could in principle be solved by one of the two following 
proposals: 
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● Two homochiral complexes are present only distinguished by the sixth external 
ligand (Cl, CH2Cl2, etc.).  
● The two species are ∆2-[Ru(2b)Cl]+ and Λ2-[Ru(2b)Cl]+. 
 
 Molecular modelling of the two latter isomers of [Ru(2b)Cl]+ indicates the greater 
stability of the ∆2-configuration by ca. 3 kcal/mol, mainly because of the steric 
interaction of the phenyl rings with the ligand backbone disfavoring Λ2 (Figure 4.15). 
 
 
Figure 4.15. Molecular modelling of [Ru(2b)Cl]+ (PM3-TM, Titan 1.05, Schrödinger Inc.) 
 
 This would mean that regardless of the two possibilities proposed above the more 
stable diasteromer (∆) is present in excess anyway. The importance of this for the 
interpretation of the CD-spectra and particularly for the correlation to the absolute 
configuration will become obvious later. 
 
4.4 CD-Spectroscopy 
 
The measurement of circular dichroism (CD) has proved to be a very valuable tool 
for the examination of conformational changes in chiral assemblies. It could be used 
with great success for the investigation of secondary structures of peptides. This is 
mainly done by comparison of a given spectrum with known characteristic signal 
patterns (Figure 4.16). 
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Figure 4.16. Characteristic CD signals for certain secondary structures in proteins 
 
Such a reference system could also be an extremely useful tool for our ligand 
system, because it would allow the determination of solution state structures of 
unknown metal complexes of 2 with regard to coordination geometry and absolute 
configuration.  
In the special case of ligand system 2, an empirical method for the rationalization of 
CD-signals on the basis of sector rules for the pyridine chromophore has been 
reported by Palmer.[1] These rules for the n-π*-transition have been used for their 
subject of investigation, metal complexes of macrocyclic pyridine crown ether 18 
(Figure 4.17). Likewise they apply for ligand system 2. 
Ph
N
O O
OO
O
N
Y Y
Ph
+
M
18
schematic representation
of metal complexes with 2
 
Figure 4.17. Pyridine crown ether 18 and proposed sector rules for n→π*-transitions by Palmer et al. 
(+ und – correspond to the sign of the CD-signal for the presence of substituents above the pyridine 
ring. Below this plane the signs are inverted.) 
 
 49
If the sector rules are employed for the prediction of CD-signals in our case, the 
octahedral ∆2-configuration on the right of Figure 4.17 would yield a positive sign for 
the n-π*-transition. This is because the right arm is placed above the pyridine plane in 
the sector indicated with “+”. The left arm is located below this plane beneath the 
sector given a “– “. A positive sign is resulting due to the fact that signs are inverted 
under the pyridine plane, a consequence of the C2-symmetry. 
Nevertheless, these sector rules can often not fully describe the spectral properties 
because they only take into account the pyridine chromophore rather than the 
contribution from the overall shape. In general, they give a good hint but not more. 
The spectra of most of the complexes show patterns of a complexity that can not be 
explained by this simple sector model. Nevertheless, in some cases good agreement 
could be found.  
Before the measurement of the CD-spectra the corresponding UV absorption 
spectra were collected for all compounds in question. Table 4.5 shows the position of 
the maxima of the n-π*-transition. This absorption can be observed as a peak on the 
higher wavelength side of the very intense π-π*-bands, often only as a shoulder 
(Figure 4.18). 
 
Figure 4.18. Typical UV-spectrum of complexes with 2 (in this case [Zn(2a)](ClO4)2) 
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Complex λmax(n-π*) 
[nm] 
Complex λmax(n-π*) 
[nm] 
Complex λmax(n-π*) 
[nm] 
[Mn(2a)(H2O)2](ClO4)2 
*THF 
244 
 
- 
   
[Fe(2a)(H2O)2](ClO4)2 
*THF 
242 [Fe(2b)(H2O)](ClO4)2 
*2 H2O 
222   
[Co(2a)](ClO4)2 238 [Co(2b)(THF)](ClO4)2 
*H2O 
231 [Co(2c)(H2O)](OTf)2 232 
[Ni(2a)](ClO4)2 
*H2O*THF 
247 [Ni(2b)](ClO4)2 
*2 H2O 
230   
[Cu(2a)](ClO4)2 
*H2O*THF 
245 [Cu(2b)](ClO4)2 
*H2O 
244   
[Zn(2a)](ClO4)2 242 [Zn(2b)](ClO4)2 
*H2O 
267 [Zn(2c)](ClO4)2 
*H2O*CH3CN 
241 
[Cd(2a)(?](ClO4)2 243 [Cd(2b)](ClO4)2 
*THF 
237   
[Mg(2a)(H2O)2](ClO4)2 244 [Co(2b)(THF)](OTf)2 231   
 
Table 4.5. Position of n-π*-band of complexes with 2 
 
As can be seen, the usual peak wavelength varies between 230nm and 250nm. The 
only exception is the zinc complex with ligand 2b having the maximum at 267nm. It is 
not clear why this is the case. 
CD-spectra were recorded in the range from 200nm to 300nm of ca. 10-4 M 
solutions in CH3CN (see NMR-solvent: CD3CN) in 1mm cylindrical cuvettes. The 
solutions were stored for one week and the measurements repeated to exclude slow 
isomerization reactions or degradation. Like with the NMR-samples no change could 
be observed in comparison to the initial spectra. The free ligands show no detectabe 
CD-signals in the region of the n-π*-transition. Therefore, the observed signals can be 
unambiguously attributed to the corresponding complexes. 
 
 
 
 
 
 
 
 51
● Complexes with Ligand 2a 
 
Figure 4.19 shows the CD-spectra of all complexes [MII(2a)(X)]2+.  
 
Figure 4.19. CD-spectra of complexes of 2a 
 
Out of the many spectra two repeating patterns can be extracted. The first group is 
populated by the complexes of manganese, iron, cadmium and magnesium (Figure 
4.20). 
 
Figure 4.20. CD-spectra of MnII-, FeII-, CdII- and MgII-complexes with 2a 
 
The four patterns differ only very slightly from each other. For the iron species the 
crystal structure shows Λ2−pentagonal-bipyramidal geometry. From the solutions of 
 52
CdII with 2a C2-symmetry can be deduced. Taking these facts together the probability 
for all these complexes to be Λ2−pentagonal-bipyramidal also in solution is very high.  
The second group consists of nickel(II), copper(II) and zinc(II) (Figure 4.21). 
 
 
Figure 4.21. CD-spectra of NiII-, CuII- and ZnII-complexes with 2a 
 
These signals also exhibit a high degree of similarity. The zinc(II) complex is known 
to be a Λ2-configured trigonal-bipyramide (X-ray) and to exist only as one form in 
solution (NMR). Therefore it is very likely that the solid state structure is retained in 
solution. In consequence, nickel(II) and copper(II) should be ∆2−species with trigonal-
bipyramidal geometry because of the mirror-image behavior of the CD-spectrum of 
zinc(II) indicating an almost enantiomeric relationship. It is interesting to note that 
simply by exchanging the metal, two pseudo-enantiomeric complexes can be 
prepared from the same ligand with the same stereo-information. 
The case of cobalt(II) remains unclear because further structural information and an 
appropriate comparison like for the other complexes is not available. 
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● Complexes with Ligand 2b 
 
CD-spectra of [MII(2b)(X)]2+ are given in Figure 4.22. 
 
Figure 4.22. CD-spectra of complexes of 2b 
 
The  spectra show less similarity among each other compared with the ones for 2a 
but still a few characteristic patterns can be extracted. The spectra for copper(II) and 
zinc(II) with 2b resemble very strongly their counterparts with ligand 2a which were 
trigonal-bipyramidal (Figure 4.23).  
 
Figure 4.23. CD-spectra of CuII- and ZnII-complexes with 2b 
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In the case of [Zn(2b)]2+ the solid state structure shows exactly this geometry with 
∆2-configuration and forms upon dissolving in CH3CN only one species (NMR). The 
assignment of ∆2 also for the solutions of CuII and ZnII is in complete agreement with 
the mirror-image CD-spectrum of the opposite configured [Zn(2a)]2+ (vide supra). 
Again it is a noteworthy finding that exchanging the two isosteric ligands 2a and 2b 
forms pseudo-enantiomers upon complexation with zinc(II). Only two donor atoms 
have to be altered for this purpose. 
Also very interesting are the spectra of cobalt(II) and iron(II) (Figure 4.24). 
 
Figure 4.24. CD-spectra of FeII- and CoII-complexes with 2b 
 
In this case, a very characteristic broad peak from ca. 200nm to 260nm can be 
observed, clearly distinguished from the other coordination geometries discussed 
above. Cobalt(II) exhibits ∆2-octahedral geometry in the solid state. As predicted with 
the sector rules introduced above a positive CD-band is observed. Here the 
assigment is relative unambiguous because of the simplicity of the signal set. 
Another hint is the CD-spectrum of the two octahedral ruthenium(II)-species in 
comparison to CoII (Figure 4.25), also showing a net spectrum with positive signals 
only. As discussed earlier this is due to the predominance of the ∆2-configuration and 
is one more indication for the retention of the solid state CoII-structure in solution. 
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Figure 4.25. Comparison of the RuII- and the CoII-CD-spectra with 2b 
 
The spectra of NiII and CdII could not be interpreted. In the case of CdII this is not 
very surprising in the light of the existence of probably more than one species in 
solution (NMR). 
 
● Complexes with Ligand 2c 
 
Finally, the CD-spectra of the two complexes with 2c are shown in Figure 4.26. 
 
Figure 4.26. CD-spectra of [Co(2c)(H2O)](OTf)2 and [Zn(2c)](ClO4)2*H2O*CH3CN 
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The spectrum of the zinc complex is as expected not well-defined because more 
than one species is present in solution (NMR). The CoII-complex in contrast exhibits 
a nice ∆2- octahedral pattern (vide supra) as was seen in the crystal structure. 
 
In conclusion, most of the metal complexes with 2 could be assigned to one specific 
coordination geometry and a determined configuration in solution by comparison and 
further information from NMR and X-ray. The cases where it was known from prior 
findings that no defined structures form upon dissolving did indeed stand out 
because of their strange behavior regarding CD-spectra. In almost every case the 
solid and the solution state structures are similar.  
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5 Multinuclear Assemblies  
 
5.1 Introduction 
 
The subject of investigation so far was the stereoselectivity of mononuclear 
complexes with ligands 2. A different approach is the controlled construction of 
multinuclear chiral structures, important especially in the field of supramolecular 
chemistry (see Section 1). Rapidly emerging classes of polymeric metal-containing 
structures are on the one hand so-called “coordination polymers”[1] (infinitely 
extending metal-ligand assemblies with bridging organic ligands) and on the other 
“inorganic-organic hybrid polymers”[2] (metal-centers, modified by organic ligands and  
connected by inorganic bridges). Although these fields have experienced tremendous 
attention over the last years, the asymmetric synthesis of chiral structures has been 
devoted relatively little effort. One of the most prominent chiral structures is the helix. 
Enantiopure, one-dimensional helices have been reported for coordination polymers 
in a few instances.[1] In contrast, the domain of inorganic-organic hybrid polymers has 
seen only very recently a first example of the generation of an enantiopure one-
dimensional helical chain.[3]  
In our case the pentagonal-bipyramidal geometry seemed ideally suited for the 
construction of one-dimensional polymeric chains because of the orientation of the 
two apical coordination sites perpendicular to the pentagonal plane and lying on one 
straight line. The best candidate on the metal part with this geometry soon was 
realized to be CdII (in combination with ligand 2a), known for its tendency to form 
halogen bridged one- or two-dimensional polymeric structures.[4]  
 
5.2 Synthesis and Structural Analysis 
 
The procedure for the preparation involved refluxing cadmium(II) halides with ligand 
2a in methanol (Scheme 5.1). 
N
OO
O
N N
O
Ph Ph
2a
MeOH, reflux
CdX2 (1.0 equiv.)
1[Cd(2a)X4Cd]8
19 (X = Cl): 57%
20 (X = Br): 76%
 
Scheme 5.1. Synthesis of the polymeric cadmium species 
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The polymeric nature of the products was very likely because of their very low 
solubility. The exact structure remained at first unclear, of course. After collecting as 
much analytical data as possible, the following facts were known: 
 
● Elemental analysis: Ligand to CdX2 = 1 : 2 
● Mass spectrometry: Main species [Cd(2a)X]+ and [CdX3]- 
● 1H-NMR (CD3CN): very low solubility but clearly one C2-symmetrical species 
● CD-spectroscopy (CH3CN): 
 
  → Λ2-pentagonal-bipyramidal 
 
All these findings finally gave an idea of the underlying design principle. Noteworthy 
is especially the role of CD-spectroscopy which gives an accurate prediction of the 
coordination geometry as well as the absolute configuration. This demonstrates the 
power of the approach developed in the last section. 
Finally it was possible to grow single crystals suitable for X-ray analysis by slow 
vapor-diffusion of Et2O into a saturated solution of the Cd-species in CH3CN. The 
structure determination completely confirmed the prediction (Figure 5.1, Table 5.1) 
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       a)   b)  
Figure 5.1. Crystal structures of the asymmetric units of a) 19 and b) 20  (hydrogen atoms omitted for 
clarity) 
 
Table 5.1. Crystal data for cadmium complexes 19 and 20 
 
∞
[Cd(2a)Cl4Cd] (19) ∞[Cd(2a)Br4Cd] (20) 
formula C27H27Cd2Cl4N3O4 C27H27Br4Cd2N3O4 
crystal appearance colorless stick colorless prism 
mol. weight 824.24 1001.94 
crystal system monoclinic orthorhombic 
space group P21 P212121 
a [Å] 8.6650(9) 9.0518(7) 
b [Å] 12.2190(8) 12.5611(7) 
c [Å] 29.130(3) 29.0084(15) 
α [°] 90 90 
β [°] 95.297(12) 90 
γ [°] 90 90 
volume [Å 3] 3071.0(5) 3298.3(4) 
Z 4 4 
ρ [g cm-1] 1.783 2.018 
µ [mm-1] 1.770 6.170 
crystal size [mm] 0.20*0.05*0.03 0.12*0.10*0.10 
temperature [K] 173(1) 173(1) 
radiation [Å] MoKα ( *λ = 0.71073) MoKα (λ = 0.71073) 
θ max [°] 1.81 < θ < 25.87 2.14 < θ < 25.86 
measured reflections 31456 23444 
independent reflections 11538 6341 
reflections in refinement 7944, I ≥ 2σ(I) 4401, I ≥ 2σ(I) 
R[a] 0.0313 0.0344 
wR2[b] 0.0575 0.0634 
R[a] (all data) 0.0560 0.0588 
wR2 (all data) 0.0620 0.0684 
abs. structure param. 0.00(3) – 0.011(14) 
[a] R factor definition: R = Σ (||F0| – |Fc||) / Σ |F0|. [b] SHELX-97 wR2 factor definition: wR2 = [Σ w(F02 – 
Fc2)2 / Σ w(F04)]1/2. Weighting scheme: w = 1 / [σ2(F0)2 + (np)2], p = [F02 + 2 Fc2] / 3. 
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The structures of 19 and 20 are very similar and follow the same design principles. 
Both consist of unprecedented one-dimensional chains of pentagonal-bipyramidal 
coordinated Cd-centers, connected by only slightly distorted tetrahedral CdX4 units 
via bridging halogens (Figure 5.2). All bond lengths and angles are in the normal 
range. An obvious difference between the two structures is the increase in the helical 
pitch (19: 8.67Å vs. 20: 9.05Å), resulting from the different bridging X-Cd bond length 
(Cd-Cl: 2.503-2.601Å vs. Cd-Br: 2.636-2.729Å). 
 
 
Figure 5.2. 1D-chain subunits of  a) 19 and b) 20 
 
In the case of 19, two unique chains can be distinguished, differing only very slightly 
from each other. Essentially they can be regarded as almost identical, like in 20, 
where only one chain can be found. Regarding stereochemistry, only Λ2-configured 
metal centers are present, yielding exclusively P-helical chains. The stacking of the 
individual chains is parallel to each other and to the crystallographic axis a, thereby 
creating a highly directed, helically ordered assembly. In both compounds, every 
other chain is stacked upside down, resulting in a deviation of the connecting Cd-
tetrahedra alternately to the right and to the left with respect to the mirror-plane 
bisecting the pyridine ring. Obviously, this does not change the overall helicity of the 
assembly.  These columns are ordered in a zig-zag-fashion (in the plane normal to 
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the axis a) (Figure 5.3) and each neighboring chain is shifted by half of the helix pitch 
(normal to axis b) (Figure 5.4). 
 
 
Figure 5.3. View normal to the crystallographic axis a for a) 19 and b) 20 
 
 
Figure 5.4. View normal to the crystallographic axis b for a) 19 and b) 20 
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In conclusion, it could be shown that ligand 2a is capable of inducing helical 
topology in inorganic-organic hybrid polymers with unprecedented design and 
complete stereoselectivity. This constitutes the first example of homochiral, non-
racemic, one-dimensional helices with an extended network of bridging halogens. 
Furthermore, the structure elucidation before X-ray analysis demonstrates the 
predictive power of CD-spectroscopy for this purpose. 
 
References: 
 
[1]  Reviews: a) C. Janiak, J. Chem. Soc., Dalton Trans. 2003, 2781-2804; b) S. 
Kitagawa,  R. Kitaura, S.-I. Noro, Angew.Chem. Int. Ed. 2004, 43, 2334-2375. 
 Selected very recent examples: a) R. Wang, L. Xu, X. Li, Y. Li, Q. Shi, Z. Zhou, 
M. Hong, A.S.C. Chan, Eur. J. Inorg. Chem. 2004, 1595-1599; b) S.P. Anthony, 
T.P. Radhakrishnan, Chem. Commun. 2004, 1058-1059; c) U. Siemeling, I. 
Scheppelmann, B. Neumann, A. Stammler, H.-G. Stammler, J. Frelek, Chem. 
Commun. 2003, 2236-2237; d) N. Niklas, F. Hampel, R. Alsfasser, Chem. 
Commun. 2003, 1586-1587; e) A.N. Khlobystov, M.T. Brett, A.J. Blake, N.R. 
Champness, P.M.W. Gill, D.P. O’Neill, S.J. Teat, C. Wilson, M. Schröder, J. Am. 
Chem. Soc. 2003, 125, 6753-6761. 
[2] Reviews: a) P.M. Forster, A.K. Cheetham, Topics in Catalysis 2003, 24(1-4), 
79-86; b) P.J. Hagrman, D. Hagrman, J. Zubieta, Angew. Chem. Int. Ed. 1999, 
38, 2638-2684. 
[3] E.V. Anokhina, A.J. Jacobson, J. Am. Chem. Soc. 2004, 126, 3044-3045. 
[4] F.A. Cotton, G.W. Wilkinson, C.A. Murillo, Advanced Inorganic Chemistry, 
Wiley-Interscience, New York 1999 (6th edition). 
 
 
 
 
 
 
 
 
 
 
 63
6 Results and Discussion 
 
The structural characteristics for ligands 2 are summarized in Tables 6.1-6.3. The 
depicted polyhedron for an individual metal indicates the proposed geometry in 
solution and in the solid state, as deduced from X-ray analysis, NMR- and CD-
spectroscopy (vide supra). The preference for a single configuration is indicated by 
the proper descriptor. If solid and solution state structures differ from each other or 
more than one species is formed, this is also stated. 
 
Solid and Solution State Structures (X-Ray/NMR/CD)  
N
OO
O
N
Ph
N
O
Ph
2a
 
25Mn 
 
Λ2 
26Fe 
 
Λ2 
27Co 
? 
28Ni 
 
∆2 
29Cu 
 
∆2 
30Zn 
 
Λ2 
43Tc 44Ru 
 
 
45Rh 46Pd 47Ag 48Cd 
 
Λ2 
 
Table 6.1. Structures of transition-metal complexes with ligand 2a 
 
 
Solid and Solution State Structures (X-Ray/NMR/CD)  
N
SS
O
N
Ph
N
O
Ph
2b
 
25Mn 26Fe 
 
∆2 
27Co 
 
∆2 
28Ni 
 
? 
 
29Cu 
 
∆2 
30Zn 
 
∆2 
43Tc 44Ru 
 
∆2 > Λ2 
45Rh 46Pd 47Ag 48Cd 
 
not uniform 
  
Table 6.2. Structures of transition-metal complexes with ligand 2b 
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Solid and Solution State Structures (X-Ray/NMR/CD)  
N
NN
O
N
Ph
N
O
Ph
2c
 
25Mn 
 
 
26Fe 
 
 
27Co 
 
∆2 
28Ni 
 
 
29Cu 
 
 
30Zn 
 
not uniform 
43Tc 44Ru 
 
 
45Rh 46Pd 47Ag 48Cd 
 
 
 
Table 6.3. Structures of transition-metal complexes with ligand 2c 
 
 
6.1 Comparison by Coordination Geometry 
 
● Pentagonal-Bipyramidal  
Metal complexes with coordination number (CN) seven[1] are rather rare and 
represent only approximately 1.8% of the reported structures for transition metal 
complexes (Cambridge Structural Database).[1d] Among the transition metals, this CN 
is not evenly distributed and is found predominantly with second and third-row 
elements of the early transition metals (Figure 6.1). 
 
Figure 6.1. Distribution of σ-heptacoordinate complexes through the transition metal series 
(reproduced from ref. 1d) 
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For the 3d-metal series, CN seven is usually found only with multidentate ligands 
and is dominated by the pentagonal-bipyramide. Typically, pentadentate ligands with 
a strong conformational preference for a coplanar coordination mode of the five 
donor groups are employed, for example macrocyclic ligands (like 21[2]) or ligands of 
the imine- or hydrazone-type (like 22[3]) derived from 2,6-diacetylpyridine (Figure 6.2). 
N
N N
HN NH
N N
22
O
O
O
O
O
21
 
Figure 6.2. Typical ligands for the induction of pentagonal-bipyramidal geometry 
 
For pentagonal-bipyramidal coordination geometries, the existence of stereogenic 
elements other than stereogenic carbon atoms in the ligand is connected to the 
deviation of certain parts of the ligand from the pentagonal plane (vide supra). This 
behavior is realized in a few cases, manifesting itself in a helical twist of the two 
ligand halves in order to release steric repulsion of the two ends of the ligand arms.[4] 
If the ligand itself bears no chiral information, this helical arrangement is formed as a 
racemic mixture. 
Exclusive formation of right-handed helices is observed for ligand 2a upon 
complexation with MgII, MnII, FeII and CdII (vide supra). Although a relative small 
number of precedences of pentagonal-bipyramidal complexes with topologically 
linear ligands (see Figure 6.1) have been reported with these metals,[5] this complete 
stereoselectivity has to the best of my knowledge not been reported for a pentagonal-
bipyramidal system, both in mononuclear as well as in polynuclear assemblies. 
 
● Octahedral  
The octahedron is probably the most important coordination polyhedron for metal 
complexes. Therefore, the focus in the stereoselective synthesis of chiral-at-metal 
compounds always has been on this coordination geometry. A large number of these 
complexes have been reported with a great variety of different ligands.[6]  
Octahedral complexes are also formed with ligands 2b (FeII, CoII, RuII, CdII) and 2c 
(CoII) (Tables 6.2-6.3). In the case of pentadentate chelators, Bernauer´s ligands 23 
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and 24 (Figure 6.3.) are known to show complete diastereoselectivity upon 
complexation in many instances.[7] 
N
HNNH
O OH OHO
R R
N
NN
OH
O
HO
O
23 24
 
Figure 6.3. Bernauer´s pentadentate ligands  
 
Therefore, the selectivity observed with the closely related ligands 2 is not 
surprising. However, the reversal of the configuration observed for the cobalt (∆2) and 
the cadmium (Λ2) complexes with 2b in the solid state structures is rather unusual. 
This phenomenon has its origin probably in the change of ionic radii (octahedral Co2+: 
0.75Å vs. octahedral Cd2+: 0.95Å), but remains largely unexplained. However, as has 
been observed by NMR-spectroscopy (vide supra), the CdII-complex with 2b shows 
not a single species in solution. Therefore, the significance of this finding is 
questionable with respect to stereoselectivity.  
 
● Trigonal-Bipyramidal 
Metal complexes with coordination number five are usually not ideally suited for 
high configurational stability because of the tendency for pseudo-rotation and/or 
dissociative/associative ligand exchange processes leading to favorable tetrahedral 
or octahedral species. The employment of multidentate ligands is often 
advantageous in this respect, suppressing these reactions to a great extent. 
However, because of the problems mentioned above, the stereoselective synthesis 
of e.g. trigonal-bipyramidal complexes with the metal as stereogenic center is still a 
challenging task. Predetermination of chirality with this coordination geometry is 
preferentially encountered with tripodal ligands.[8] Only three examples with 
topologically linear ligands have been reported.[9]  
Trigonal-bipyramidal complexes are formed upon complexation with all ligands 2, 
especially with the late transition metals NiII (2a), CuII (2a-2b) and ZnII (2a-2c). This 
coordination geometry is not unusual for these metals and has been observed in 
numerous racemic cases before.[10] Complete stereoselection is observed in zinc(II) 
complexes with ligands 2a (Λ2) and 2b (∆2), in the solid state as well as in solution. 
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This configurational reversal has up to date only been encountered with the 
employment of enantiomeric (trivial) or diastereomeric ligands.[9b] Only the exchange 
of two (non-stereogenic) donor atoms (O vs. S) is sufficient for this purpose. This 
phenomenon has not been encountered so far. Maybe the closest analogy can be 
seen in the cobalt complexes of ligands 25 and 26 (Figure 6.4). While 25 forms 
octahedral ∆2-CoIII-complexes, 26 gives rise to a mixture of cobalt(III) complexes, in 
which one species was identified to possess the Λ2-configuration.[11] 
N
HNNH
O OH OHO
H3C CH3
25 26
N
NN
O OH OHO
H3C CH3
 
Figure 6.4. Bernauer`s ligands giving rise to two opposite configurations 
 
Interestingly, the trigonal-bipyramidal zinc complex with ligand 2c gives also a 
mixture of species in solution as determined by NMR. Perhaps this has to be 
attributed to the presence of the tertiary amine donor, both in 2c and in 26. Especially 
in the highly crowded trigonal-bipyramidal zinc complex with 2c, the additional methyl 
group is probably exerting a strong steric strain upon the ligand backbone. This steric 
repulsion, although not strong enough to make pentacoordination of the ligand 
impossible in the crystal structure, is likely to be avoided in solution by dissociation of 
one arm from the metal. 
 
6.2 Comparison by Ligands 
 
● Ligand 2a 
As Table 6.1 shows, ligand 2a favors the formation of either pentagonal-bipyramidal 
(MnII, FeII, CdII) or trigonal-bipyramidal (NiII, CuII, ZnII) complexes. While the first 
coordination geometry is uniformly formed with complete Λ2-selectivity, the latter 
case exhibits a reversal in configuration from ∆2 (Ni, Cu) to Λ2 (Zn). This 
phenomenon goes largely unexplained. Why the usually often favored octahedron 
was never observed, also remains unclear. 2a is able to accommodate rather large 
cations like CdII or YbIII. 
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● Ligand 2b 
The survey in Table 6.2 clearly demonstrates the strong preference of 2b to form 
∆2-species with first-row transition metals, either in an octahedral fashion (FeII, CoII) 
or by adopting the trigonal-bipyramide (CuII, ZnII). With elements of the second row 
(RuII, CdII), the stereoselectivity especially in solution apparantly drops. This is 
probably because of the difficulty of 2b to accomodate these large cations. In 
comparison with 2a, this would not be surprising because of the increased van-der-
Waals-radius by exchanging oxygen with sulfur, making the binding cavity smaller. 
 
● Ligand 2c 
Due to the small number of examples with 2c, only statements on the basis of 
limited experimental evidence can be made. The coordination behavior (Table 6.3) 
seems similar to the one for 2b, although the stereoselectivity for the zinc complex is 
reversed (Λ2) in the solid state. This selectivity resembles more the characteristics for 
2a. As has been stated before, the additional methyl group could prove to be a 
serious problem because of the potential build-up of steric strain resulting in lowering 
the configurational preference (vide supra). 
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7 Summary 
 
In the course of this thesis, the following results could be obtained: 
 
● Development of a facile modular synthesis for the preparation of the new 
ligand system 2  
The procedures for the assembly of 2a-c could be optimized for the preparation of 
multigram quantities of these ligands. The validity of the modular approach has 
been demonstrated and will allow rapid variation of the ligands in the future. The 
set of building blocks can easily be expanded because of the generality of the final 
assembly step. 
 
● Experimental simple preparation and purification of a large number of 
different metal complexes of ligand system 2  
Especially the perchlorate complexes proved to be accessible in analytically pure 
form by an easy precipitation strategy without the need for additional purification 
steps.  
 
● Generation of a predictive model for complex properties in solution using 
CD-spectroscopy 
This constitutes the main finding of this work. It is now possible for ligand system 2 
to assign coordination geometry and configurational preference for unknown metal 
complexes in solution solely from the information obtained by CD-measurements 
as demonstrated for the polymeric cadmium species (see Section 5). This holds 
true for a set of very important coordination polyhedra including the octahedron, 
the trigonal-bipyramide and the pentagonal-bipyramide (Figure 7.1). With this 
respect it could be almost as valuable as in the case of elucidation of the 
secondary structure of proteins by CD-spectroscopy. It has to be emphasized that 
the benefit is not to complete missing crystal structures but rather to have proper 
information about the solution behavior of certain species. This could prove to be 
very important for the rationalization of reactivity and selectivity with respect to 
application in asymmetric catalysis. For most known catalytic systems employed 
today, few or sometimes nothing is definitely known in solution, mostly relying on 
mere speculation. 
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Figure 7.1. Characteristic CD-patterns for specific coordination geometries 
 
● Stereoselective synthesis of both pseudo-enantiomers of zinc complexes 
from ligands with only one stereochemistry 
Up to date only the employment of enantiomeric (trivial) or diastereomeric ligands 
(vide supra) is suitable for the generation of complexes with opposite configuration 
at the metal center. With ligands 2 it could be shown that the completely 
stereoselective construction of trigonal-bipyramidal zinc(II) complexes (which is 
also rather rare using topologically linear ligands) with  2a and 2b leads to pseudo-
enantiomeric complexes in the solid (Figure 7.2) and the solution state (Figure 
7.3). In this case, only the exchange of two donor atoms (O vs. S) is necessary for 
this purpose. This phenomenon was to the best of my knowledge not observed 
before. 
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Figure 7.2. Pseudo-enantiomeric crystal structures of [Zn(2a)]2+ and [Zn(2b)]2+  
 
 
Figure 7.3. Mirror-image relationship of the CD-spectra of [Zn(2a)](ClO4)2 and [Zn(2b)](ClO4)2*H2O 
 
● Stereoselective synthesis of both pseudo-enantiomers of metal complexes 
from only one ligand by solely exchanging the metal 
This phenomenon is related to the preceeding finding. It could be shown that with 
ligand 2a, both pseudo-enantiomeric forms of trigonal-bipyramidal complexes are 
accessible in solution simply by varying the metal from NiII/CuII (∆2) to ZnII (Λ2) 
(Figure 7.4).  
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Figure 7.4. Configurational switch observed for the CD-spectra of [(Ni or Cu)(2a)](ClO4)2*H2O*THF  
and [Zn(2a)](ClO4)2  
 
The same could be shown for the solid state structures of (distorted) octahedral 
complexes of 2b with CoII (∆2) and CdII (Λ2) (Figure 7.5). However, this statement 
can not be extended for the solution state because of the presence of more than 
one species for the cadmium complex. 
            
Figure 7.5. Pseudo-enantiomeric crystal structures of [Co(2b)(THF)]2+ and [Cd(2b)(ClO4)]+  
 
● Unprecedented determination of helical chirality in pentagonal-bipyramidal 
coordination compounds 
This phenomenon has been observed in a number of metal complexes of ligand 
2a, both in mononuclear (MgII, MnII, FeII, CdII) (Figure 7.6) as well as in 
polynuclear assemblies (CdII) (Figure 7.7). Besides the fact that this coordination 
geometry itself is rather unusual, the predetermination of helical chirality in 
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complexes of this kind has to the best of my knowledge not been reported up to 
date. 
  
 
Figure 7.6. Pentagonal-bipyramidal coordination geometry in the crystal structure [Fe(2a)(H2O)2]2+ 
with exclusively right-handed helicity 
        
Figure 7.7. Selective right-handed helix formation in one-dimensional polymeric ∞[Cd(2a)Br4Cd] 
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8 Experimental Section 
 
8.1  General  
 
Where indicated, reactions were carried out under a dry, oxygen-free atmosphere of 
N2 using Schlenk-technique. Commercially available reagents were used as received. 
DMF, CH3CN and CH2Cl2 were distilled over P4O10 and stored under N2 over 
molecular sieves 3Å. EtOH and MeOH were dried over Mg and stored under N2. 
THF, 1,4-dioxane and Et2O were dried with Na/benzophenone and stored over Na-
wire under N2. EtOAc, CH2Cl2, MeOH and hexanes for chromatographic separations 
were distilled before use. For column chromatography silica gel Geduran 60 (Merck, 
0.063-0.200 mm) was used. TLC-analysis was done on silica gel 60 F254 (Merck) 
coated on aluminium sheets. 
NMR-spectra were recorded on Bruker Avance 300 (1H: 300 MHz, 13C: 75.5 Mhz) 
and Bruker Avance 600 (1H: 600 MHz) with TMS as internal standard. IR-
spectroscopy was done on a Mattson Genesis Series FT-IR (sample preparation as 
indicated). X-ray analysis was performed by the Crystallography Laboratory 
(University of Regensburg, M. Zabel, S. Stempfhuber) and the Crystallography 
Laboratory (University of Kansas, D. R. Powell). Elemental analysis (Heraeus 
elementar vario EL III) and mass spectrometry (Finnigan ThermoQuest TSQ 7000) 
were done by the Central Analytical Laboratory (Universität Regensburg). CD-
spectra were recorded on a Jasco J-710 spectropolarimeter using ca. 10-4M CH3CN-
solutions (HPLC-grade) in 1mm-cuvettes (cylindrical). 
 
8.2 Ligand Synthesis 
 
2,6-Pyridinedicarboxylic acid dimethyl ester 
 
N
OMeMeO
O O
 
 
100.0 g (598.4 mmol) 2,6-pyridinedicarboxylic acid were suspended in 700 mL 
MeOH and treated cautiously with 5.0 mL conc. sulfuric acid. The mixture was 
heated to reflux for 5 h. The product crystallized upon cooling to room temperature, 
was collected on a Büchner-funnel and washed with 50 mL MeOH and Et2O. After 
drying in vacuo the product was obtained as a colorless solid (104.3 g, 89%). 
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M.p. 122-124°C. 1H-NMR (300 MHz, CDCl3): δ = 8.32 (d, J = 7.9 Hz, 2 H), 8.04 (t, 
J = 7.7 Hz, 1 H), 4.04 (s, 6 H). 13C-NMR (75.5 MHz, CDCl3): δ = 165.0, 148.2, 138.3,  
128.0, 53.2. 
 
2,6-Bis(hydroxymethyl)pyridine (3) 
 
N
OHHO
 
 
A suspension of 34.30 g (175.7 mmol, 1.0 eq.uivs.) 2,6-pyridinedicarboxylic acid 
dimethyl ester in 470 mL dry EtOH was cooled in an ice-bath and treated with 31.05 
g (820.7 mmol, 4.67 equivs.) NaBH4 in portions. A reflux-condenser with a drying 
tube was placed on the flask and the mixture was stirred for 1 h at 0°C. The ice-bath 
was removed and stirring was continued until the exothermic reaction had ceased. (If 
the reaction gets too vigorous, the flask should be cooled with a cold water-bath.) 
After further stirring for 3 h at ambient temperature, the mixture was refluxed for 10 h. 
The solvent was removed in vacuo, the residue was treated with 120 mL acetone 
and the mixture refluxed for 1 h. The solvent was evaporated again and 120 mL 
saturated aqueous K2CO3-solution was added. Heating for 1 h under reflux was 
followed by removing the solvent under vacuum. The residue was dissolved in 470 
mL water and the solution was extracted continously in a liquid-liquid-extractor 
overnight to yield 20.42 g (84%) of a colorless solid. 
 
M.p. 114-115°C. 1H-NMR (300 MHz, DMSO-d6): δ = 7.76 (t, J = 7.7 Hz, 1 H), 7.30 (d, 
J = 7.7 Hz, 2 H), 5.34 (t, J = 5.8 Hz, 2 H), 4.51 (d, J = 5.8 Hz, 4 H). 13C-NMR (75.5 
MHz, DMSO-d6): δ = 160.7, 136.9, 118.0, 64.1. 
  
2,6-Bis(bromomethyl)pyridine (10) 
 
N
BrBr
 
 
To a suspension of 24.61 g (138.3 mmol, 2.15 equivs.) N-bromosuccinimide in 220 
mL dry benzene was added 6.90 g (64.4 mmol, 1.0 equivs.) 2,6-lutidine und 130 mg 
AIBN. The mixture was heated slowly until the reaction started. After most of the 
vigorous boiling had subsided the mixture was irradiated with a 250W-light bulb and 
heated to reflux for 10 h. After evaporation of the solvent the residue was taken up in 
a minimum of hexanes, the suspension filtered and the filtrate reduced under 
vacuum. The remaining solid was subjected to column chromatography (SiO2, 
hexanes/EtOAc 10:1, Rf = 0.22). The product was obtained as a slightly brown solid 
(2.23 g, 13%). (CAUTION: The title compound and every byproduct are very 
lachrymatory! Avoid contact with skin!) 
 
M.p. 87-88°C. 1H-NMR (300 MHz, CDCl3): δ = 7.69 (t, J = 7.7 Hz, 1 H), 7.36 (d, J = 
7.7 Hz, 2 H), 4.52 (s, 4 H). 13C-NMR (75.5 MHz, CDCl3): δ = 156.7, 138.1, 122.8, 
33.5. 
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2,6-Bis(chloromethyl)pyridine Hydrochloride (7) 
 
N
ClCl
HCl
 
 
To a suspension of 2.11 g (15.2 mmol, 1.0 equivs.) 2,6-bis(hydroxymethyl)pyridine 
(3) in 15 mL dry Et2O (cooled to 0°C) was added a solution of 2.43 mL (33.4 mmol, 
3.97 g, 2.2 equivs.) SOCl2 in 3 mL Et2O. After complete addition the mixture was 
stirred at 0°C for one hour, before the ice-bath was removed and stirring was 
continued at ambient temperature for 20 hours. The white solid was collected, 
washed with Et2O and dried under reduced pressure. The product was obtained as a 
colorless solid (3.05 g, 96%). 
 
M.p. 151-152°C. 1H-NMR (300 MHz, DMSO-d6): δ = 12.61 (br s, 1 H), 7.95 (t, J = 
7.7 Hz, 1 H), 7.56 (d, J = 7.7 Hz, 2 H), 4.81 (s, 4 H). 13C-NMR (75.5 MHz, DMSO-d6): 
δ = 155.7, 139.2, 123.0, 45.9. 
 
2,6-Bis(chloromethyl)pyridine (8) 
 
N
ClCl
 
 
3.56 g (16.8 mmol) 2,6-bis(chloromethyl)pyridine hydrochloride (7) were suspended 
in 60 mL CH2Cl2. Saturated aqueous NaHCO3 (60 mL) was added slowly and the 
phases were separated. The aqueous phase was extracted with 2*30 mL CH2Cl2 and 
the combined organic phases dried over Na2SO4. After evaporation of the solvent the 
residue was recrystallized from n-hexane to yield 2.75 g (93%) product as a colorless 
solid. 
 
M.p. 74-75 °C. 1H-NMR (300 MHz, CDCl3): δ = 7.77 (t, J = 7.7 Hz, 1 H), 7.44 (d, J = 
7.7 Hz, 2 H), 4.67 (s, 4 H). 13C-NMR (75.5 MHz, CDCl3): δ = 156.4, 138.1, 122.1, 
46.4. 
 
2,6-Bis(carbamimidoylsulfanylmethyl)pyridine Trihydrochloride 
 
N
S S
NH2
NH
NH2
HN * 3 HCl
 
 
To a solution of 5.00 g (23.5 mmol, 1.0 equivs.) 2,6-bis(chloromethyl)pyridine 
hydrochlorid (7) in 100 mL EtOH was added 4.30 g (56.5 mmol, 2.4 equivs.) thiourea 
and the mixture was refluxed for 20 min. After cooling down to ambient temperature 
the solid was collected and washed with EtOH and Et2O. Drying under reduced 
pressure yielded 7.46 g (87%) of a fine colorless solid. 
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M.p. > 200 °C. 1H-NMR (300 MHz, D2O): δ = 7.94 (t, J = 7.9 Hz, 1 H), 7.51 (d, J = 7.9 
Hz, 2 H), 4.53 (s, 4 H). 13C-NMR (75.5 MHz, D2O): δ = 170.8, 154.3, 140.8, 123.6, 
35.6.  IR (KBr): ν~  = 3280 cm-1, 3080, 3000, 2870, 2590, 1653, 1612, 1435, 1279, 
1228, 1178, 1066, 937, 819, 683.  MS (ESI, H2O/CH3CN): m/z (%) = 255.7 (65), 
217.6 (38), 215.7 (100), 197.6 (32). C9H16Cl3N5S2 (364.75): calc. C 29.64, H 4.42, N 
19.20; found C 29.61, H 4.50, N 19.10.
 
 
2,6-Bis(mercaptomethyl)pyridine (11) 
 
N
SHHS
 
 
Under Ar 7.46 g (20.5 mmol, 1.0 equiv.) 2,6 Bis(carbamimidoylsulfanylmethyl)- 
pyridine Trihydrochloride were dissolved in 20 mL degassed water and 4.50 g (112.5 
mmol, 5.5 equivs.) NaOH were added. The solution was refluxed for 2 h and after 
cooling down to room temperature, the pH was adjusted to approx. 8 with degassed 
1 M HCl. The mixture was transferred to a Schlenk-separatory funnel, set under Ar, 
and the aqueous phase was extracted with 3*30 mL degassed CHCl3. The organic 
phases were collected under Ar. The combined organic layers were dried (Na2SO4) 
and evaporated under reduced pressure. Kugelrohr-distillation (p = 0.04 mbar, 
heating 130°C) yielded 1.30 g (37%) of the product as an air-sensitive slightly yellow 
oil, that was stored under N2 at 4°C. 
 
1H-NMR (300 MHz, CDCl3): δ = 7.62 (t, J = 7.7 Hz, 1 H), 7.21 (d, J = 7.7 Hz, 2 H), 
3.82 (d, J = 8.0 Hz, 4 H), 2.03 (t, J = 8.0 Hz, 2 H). 13C-NMR (75.5 MHz, CDCl3): δ = 
159.9, 137.8, 120.5, 30.8. 
 
Ethyl benzimidate (6) 
 
O
NH
 
 
42.46 g (228.7 mmol) Ethyl benzimidate hydrochloride were suspended in 200 mL 
CH2Cl2. 300 mL sat. aqueous NaHCO3 was added slowly and the phases were 
separated. The aqueous phase was extracted with 4*125 mL CH2Cl2, the combined 
organic phases dried over Na2SO4 and concentrated. The remaining crude product 
was distilled (bp 96-97°C / 4 hPa) to yield 29.69 g (87%) colorless liquid. 
 
1H-NMR (300 MHz, CDCl3): δ = 7.78 – 7.68 (m, 2 H), 7.65 – 7.51 (br s, 1 H), 7.48 – 
7.32 (m, 3 H), 4.32 (q, 2 H, J = 7.0 Hz), 1.41 (t, 3 H, J = 7.0 Hz). 13C-NMR (75.5 MHz, 
CDCl3): δ = 167.8, 132.9, 130.8, 128.4, 126.7, 61.8, 14.2. 
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(S)-4-Methoxycarbonyl-2-phenyl-oxazoline (15) 
 
N
O O
O
 
 
Under N2 a flask was charged with 28.07 g (188.2 mmol, 1.0 equivs.) ethyl 
benzimidate (6), 32.20 g (207.0 mmol, 1.1 equivs.) (S)-serine methyl ester 
hydrochloride (5) and 550 mL dry 1,2-dichloroethane. The mixture was refluxed for 
20 h, filtered and the solvent was removed in vacuo. The oily residue was dissolved 
in Et2O, filtered again and the filtrate was evaporated. The crude product (34.70 g, 
90%) was obtained as a colorless oil, that could be used for the next step without 
purification.  
 
20][ Dα  = +120.1 (c = 2.1, CHCl3). 1H-NMR (300 MHz, CDCl3): δ = 8.01 – 7.94 (m, 2 H), 
7.53 – 7.36 (m, 3 H), 4.95 (dd, 1 H, J = 10.6, 7.9 Hz), 4.69 (dd, 1 H, J = 8.7, 7.9 Hz), 
4.59 (dd, 1 H, J = 10.6, 8.7 Hz), 3.81 (s, 3 H). 13C-NMR (75.5 MHz, CDCl3): δ = 
171.6, 166.2, 131.8, 128.6, 128.3, 126.9, 69.5, 68.6, 52.7. 
 
(R)-4-Hydroxymethyl-2-phenyl-oxazoline (4) 
 
N
O OH
 
 
A 2000mL-two-necked-nitrogen-flask equipped with a thermometer and a 100mL-
dropping funnel was charged with 5.21 g (137.2 mmol, 0.55 equivs.) LiAlH4, set 
under N2 and 450 mL dry THF. The suspension was cooled with dry ice/acetone to 
-35°C and a solution of 51.18 g (249.4 mmol, 1.0 equivs.) (S)-4-methoxycarbonyl-2-
phenyl-oxazoline (15) in 80 mL THF was added dropwise in the course of 45 min so 
that the temperature did not rise above -30°C. After complete addition the mixture 
was allowed to reach 0°C and stirred in an ice-bath for 30 min. The 100mL-dropping 
funnel was replaced by a bigger one (1000 mL) and a solution of 300 g sodium 
potassium tartrate in 600 mL water was added very carefully. The yellow mixture was 
stirred at ambient temperature for additional 2 h and extracted with 4*200 mL EtOAc. 
The combined organic layers were dried (Na2SO4) and evaporated. The residue was 
purified by column chromatography (SiO2, EtOAc, Rf = 0.31). The product was 
obtained as a colorless solid (28.28 g, 64%).  
 
M.p. 97-98 °C. 20D][α  = +54.4 (c = 1.3, EtOH). 1H-NMR (300 MHz, CDCl3): δ = 7.83 – 
7.71 (m, 2 H), 7.46 – 7.36 (m, 1 H), 7.35 – 7.22 (m, 2 H), 4.52 – 4.30 (m, 3 H), 3.98 
(dd, J = 11.7, 2.9 Hz, 1 H), 3.9 – 3.5 (br s, 1 H), 3.66 (dd, J = 11.7, 3.7 Hz, 1 H). 13C-
NMR (75.5 MHz, CDCl3): δ = 165.5, 131.4, 128.24, 128.19, 127.1, 69.2, 68.1, 63.6. 
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(S)-2-Phenyl-4-tosyloxymethyl-oxazoline (17) 
 
N
O OTs
 
 
To a solution of 15.00 g (84.65 mmol, 1.0 equivs.) (R)-4-hydroxymethyl-2-phenyl-
oxazoline (4) and 26.0 mL (186.2 mmol, 18.84 g, 2.2 equivs.) dry NEt3 in 80 mL dry 
CHCl3 under N2 and at 0°C was added dropwise a solution of 17.75 g (93.12 mmol, 
1.1 equivs.) tosyl chloride in 80 mL dry CHCl3. The mixture was stirred at ambient 
temperature for 20 h, washed with 2*30 mL water, 30 mL sat. NaHCO3 and 30 mL 
water. The organic layer was dried (Na2SO4) and evaporated. The crude product was 
recrystallized from 2-propanol yielding 21.74 g (78%) slightly yellow solid.   
 
M.p. 107-111 °C. 20D][α  = +56.6 (c = 1.0, EtOH). 1H-NMR (300 MHz, CDCl3): δ = 7.86 
– 7.79 (m, 2 H), 7.77 – 7.69 (m, 2 H), 7.49- 7.20 (m, 2 H), 4.55 – 4.38 (m, 2 H), 4.33 
– 4.19 (m, 2 H), 4.05 – 3.96 (m, 1 H), 2.39 (s, 3 H). 13C-NMR (75.5 MHz, CDCl3): δ = 
166.0, 145.0, 132.5, 131.8, 129.9, 128.4, 128.3, 128.0, 127.0, 70.8, 69.8, 65.1, 21.7. 
 
(S)-2-Phenyl-4-mesyloxymethyl-oxazoline (16) 
 
N
O OMs
 
 
Under N2 3.01 g (17.0 mmol, 1.0 equivs.) (R)-4-hydroxymethyl-2-phenyl-oxazoline (4) 
were dissolved in 40 mL dry THF and cooled to -25°C external temperature. 2.60 µL 
(18.7 mmol, 1.89 g, 1.1 equivs.) dry NEt3 and 1.38 mL (17.8 mmol, 2.04 g, 1.05 
equivs.) mesyl chloride were added subsequently. The mixture was stirred at -25°C 
for 30 min, before water (50 mL) and CH2Cl2 (80 mL) were added. The organic layer 
was separated, dried (MgSO4) and the solvent evaporated under reduced pressure. 
The crude yellow oil (4.17 g, 96%) was used for the subsequent steps without further 
purification. An analytical sample was obtained by column chromatography (flash-
SiO2, hexanes / EtOAc 1:1). 
 
20
D][α  = +54.5 (c = 1.56, CH2Cl2). 1H-NMR (300 MHz, CDCl3): δ = 8.00 – 7.88 (m, 2 
H), 7.57 – 7.36 (m, 3 H), 4.69 – 4.49 (m, 2 H), 4.47 – 4.30 (m, 3 H), 3.03 (s, 3 H). 
13C-NMR (75.5 MHz, CDCl3): δ = 166.1, 131.9, 128.5, 128.4, 127.0, 70.4, 69.3, 65.4, 
37.6.  IR (film): ν~  = 3080, 3040, 2980, 2950, 2920, 1728, 1645, 1603, 1580, 1496, 
1452, 1356, 1277, 1242, 1174, 1061, 1025, 961, 833, 786, 695.  MS (DCI, NH3): m/z 
(%) = 258.2 (9), 257.2 (20), 256.1 (100). HRMS (EI): calcd for C11H13NO4S [M]+ 
255.0565, found 255.0565. 
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Pyridine-2,6-dicarbaldehyde (12) 
 
N
OO
 
 
A solution of 7.50 g (53.9 mmol, 1.0 equivs.) 2,6-bis(hydroxymethyl)pyridine (3) and 
5.98 g (53.9 mmol, 1.0 equivs.) SeO2 in 120 mL dry 1,4-dioxane was refluxed for 4 
hours. The dark mixture was filtered hot and the solvent removed. The remaining 
solid was taken up in CH2Cl2 and passed over a short column of silica. After washing 
the silica with CH2Cl2, the filtrate was reduced to yield a slightly yellow solid. This 
crude product was broken up and suspended in n-hexane (30 mL). After stirring for 
one hour, the solid was collected and washed with n-hexane.  The product was 
obtained as a very slightly pink solid (4.00 g, 55%).  
 
M.p. 124-126°C. 1H-NMR (300 MHz, CDCl3): δ = 10.18 (s, 2 H), 8.23 – 8.05 (m, 3 H). 
13C-NMR (75.5 MHz, CDCl3): δ = 192.3, 153.0, 138.4, 125.3. 
 
 
 
 
 
 
 
2,6-Bis(methyliminomethyl)pyridine (13) 
 
N
NN
Me Me
 
 
A solution of 3.95 g (58.4 mmol, 2.4 equivs.) methylamine hydrochloride in MeOH 
(100 mL) was cooled to 0°C and treated with 9.42 g (68.2 mmol, 2.8 equivs.) K2CO3. 
After stirring for one hour in an ice-bath 3.29 g (24.3 mmol, 1.0 equivs.) pyridine-2,6-
dicarbaldehyde (12) was added. The mixture was stirred at ambient temperature for 
further three hours and the solvent evaporated. The solid residue was taken up in 
150 mL CH2Cl2 and the suspension stirred for one hour. After filtering off the solid, 
the solvent was evaporated to yield a yellow oil (2.97 g, 76%). No further purification 
of the product was necessary for the next step. 
 
1H-NMR (300 MHz, CDCl3): δ = 8.31, 8.32 (2 s, 2 H), 7.85 (d, J = 7.7 Hz, 2 H), 7.68 
(t, J = 7.7 Hz, 1 H), 3.48, 3.47 (2 s, 6 H). 13C-NMR (75.5 MHz, CDCl3): δ = 163.0, 
154.2, 137.0, 121.9, 48.0. 
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2,6-Bis(N-methylaminomethyl)pyridine (14) 
 
N
HNNH
Me Me
 
 
To a solution of 2.62 g (16.3 mmol, 1.0 equivs.) 2,6-bis(methyliminomethyl)pyridine 
(13) in dry EtOH (40 mL) was added 1.23 g (32.6 mmol, 2.0 equivs.) NaBH4 in 
portions. The solution was stirred for 16 hours and water (40 mL) was added 
cautiously. This solution was extracted with 3*40 mL CH2Cl2, the combined organic 
phases dried (MgSO4) and the solvent evaporated. The residue was distilled (bp 97-
100°C / 0.08 mbar) to yield a yellow oil (1.81 g, 67%), that was stored under nitrogen 
at 4°C. 
 
1H-NMR (300 MHz, CDCl3): δ = 7.60 (t, J = 7.6 Hz, 1 H), 7.16 (d, J = 7.6 Hz, 2 H), 
3.85 (s, 4 H), 2.48 (s, 6 H), 1.78 (br s, 2 H). 13C-NMR (75.5 MHz, CDCl3): δ = 159.3, 
136.7, 120.4, 57.2, 36.2. MS (DCI, NH3): m/z (%) = 167.2 (10), 166.2 (100. HRMS 
(EI): calcd for C9H14N3 [M-H]+ 164.1188, found 164.1189. 
 
Ligand 2a 
 
N
O O
O
N N
O
Ph Ph
 
 
13.86 g (78.2 mmol, 2.2 equivs.) (R)-4-hydroxymethyl-2-phenyl-oxazoline (4) were 
dissolved in 200 mL dry DMF under N2 and cooled to 0°C. 3.27 g (81.8 mmol, 2.3 
equivs.) NaH-suspension (60% in mineral oil) were added in portions and the mixture 
was stirred for 15 min. 6.26 g (35.6 mmol, 1.0 equiv.) 2,6-bis(chloromethyl)pyridine 
(8) were added as a solid and the ice-bath was removed. Stirring was continued at 
ambient temperature for 20 h. 200 mL water and 150 mL CH2Cl2 were added 
cautiously and the phases were separated. The aqueous layer was extracted with 
2*150 mL CH2Cl2. The combined organic layers were washed with 3*100 mL water 
and dried (Na2SO4). After removal of the solvent in vacuo the residue was purified by 
column chromatography (SiO2, EtOAc to  EtOAc / MeOH 24:1) to yield 14.37 g (88%) 
of a colorless solid. 
 
M.p. 68-69 °C. 20D][α  = +62.5 (c = 0.80, CH2Cl2). 1H-NMR (300 MHz, CDCl3): δ = 8.00 
– 7.86 (m, 4 H), 7.65 (t, J = 7.7 Hz, 1 H), 7.51 – 7.35 (m, 6 H), 7.31 (d, J = 7.7 Hz, 
2 H), 4.68 (s, 4 H), 4.61 – 4.46 (m, 4 H), 4.41 – 4.34 (m, 2 H), 3.88 – 3.80 (m, 2 H), 
3.66 – 3.58 (m, 2 H). 13C-NMR (75.5 MHz, CDCl3): δ = 165.0, 157.7, 137.2, 131.4, 
128.31, 128.30, 127.6, 120.0, 74.2, 72.9, 70.5, 66.4. 1H-NMR (300 MHz, CD3CN): δ = 
7.95 – 7.84 (m, 4 H), 7.69 (t, J = 7.7 Hz, 1 H), 7.56 – 7.38 (m, 6 H), 7.30 (d, J = 7.7 
Hz, 2 H), 4.58 (s, 4 H), 4.52 – 4.40 (m, 4 H), 4.36 – 4.24 (m, 2 H), 3.76 – 3.59 (m, 4 
H). 13C-NMR (75.5 MHz, CD3CN): δ = 164.9, 159.0, 138.3, 132.4, 129.5, 129.0, 
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121.1, 74.9, 73.5, 71.0, 67.6. IR (KBr): ν~  = 3060 cm-1, 3040, 2985, 2958, 2947, 
2936, 1642, 1591, 1577, 1493, 1467, 1460, 1446, 1356, 1345, 1289, 1252, 1242, 
1130, 1076, 1059, 1025, 970, 955, 922, 785, 608.  MS (DCI, NH3): m/z (%) = 459.2 
(25), 458.1 (100). C27H27N3O4 (457.52): calc. C 70.88, H 5.95, N 9.18; found C 70.73, 
H 5.93, N 9.04. 
 
Ligand 2b 
 
N
S S
O
N N
O
Ph Ph
 
 
2.12 g (12.4 mmol, 1.0 equivs.) 2,6-bis(mercaptomethyl)pyridine (11) were dissolved 
in 100 mL dry DMF under N2 and cooled to 0°C. 1.04 g (26.0 mmol, 2.1 equivs.) 
NaH-suspension (60% in mineral oil) was added in portions and the mixture was 
stirred for until the evolution of hydrogen had ceased. 8.60 g (26.0 mmol, 2.1 equivs.) 
(S)- 2-phenyl-4-tosyloxymethyl-oxazoline (17) was added as a solid and the ice-bath 
was removed. Stirring was continued at ambient temperature overnight. 100 mL 
water and 200 mL CH2Cl2 were added and the phases were separated. The organic 
layer was extracted with 4*100 mL water and dried (MgSO4). After removal of the 
solvent in vacuo the residue was purified by column chromatography (SiO2, hexanes 
/ EtOAc 1:1 to hexanes / EtOAc 3:7) to yield 4.36 g (72%) of a slightly yellow oil, that 
solidified after several days to give a waxy slightly brown solid. 
 
M.p. 59-61 °C. 20D][α  = +21.6 (c = 1.16, CH2Cl2). 1H-NMR (300 MHz, CDCl3): δ = 7.98 
– 7.85 (m, 4 H), 7.60 (t, J = 7.7 Hz, 1 H), 7.53 – 7.32 (m, 6 H), 7.25 (d, J = 7.7 Hz, 2 
H), 4.57 – 4.39 (m, 4 H), 4.29 – 4.15 (m, 2 H), 3.89 (s, 4 H), 2.94 (dd, J = 13.3, 4.8 
Hz, 2 H), 2.65 (dd, J = 13.3, 7.8 Hz, 2 H) . 13C-NMR (75.5 MHz, CDCl3): δ = 164.5, 
158.2, 137.4, 131.5, 128.3 (2 peaks), 127.6, 121.4, 72.0, 66.5, 38.3, 36.6. 1H-NMR 
(300 MHz, CD3CN): δ = 7.94 – 7.80 (m, 4 H), 7.64 (t, J = 7.7 Hz, 1 H), 7.55 – 7.35 (m, 
6 H), 7.23 (d, J = 7.7 Hz, 2 H), 4.55 – 4.35 (m, 4 H), 4.20 – 4.05 (m, 2 H), 3.85 (s, 4 
H), 2.84 (dd, J = 13.4, 5.2 Hz, 2 H), 2.72 (dd, J = 13.4, 6.6 Hz, 2 H) . 13C-NMR (75.5 
MHz, CD3CN): δ = 164.6, 159.7, 138.6, 132.4, 129.5, 129.0, 128.9, 122.3, 72.7, 67.7, 
38.8, 37.2. IR (film): ν~  = 3074, 2978, 2930, 2910, 1970, 1912, 1820, 1731, 1646, 
1589, 1573, 1495, 1453, 1418, 1360, 1306, 1264, 1177, 1084, 1063, 1029, 967, 909, 
818, 782, 751, 694.  MS (ESI): m/z (%) = 491.2 (34), 490.1 (100). HRMS (EI): calcd 
for C27H27N3O2S2 [M]+ 489.1545, found 489.1541. 
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Ligand 2c 
 
N
N N
O
N N
O
Ph Ph
 
 
 
Under N2 a solution of 1.11 g (4.35 mmol, 2.1 equivs.) (S)-2-phenyl-4-
mesyloxymethyl-oxazoline (16) in 20 mL dry CH3CN was added dropwise to a 
solution of 342 mg (2.07 mmol, 1.0 equiv.) 2,6-bis(N-methylaminomethyl)pyridine 
(14) in 10 mL dry CH3CN. 1.14 g (8.28 mmol, 4.0 equivs.) K2CO3 were added and the 
mixture was heated to reflux for 31 h. After cooling down the suspension was filtered 
and the solvent evaporated. The residue was purified by column chromatography 
(SiO2,CH2Cl2 / MeOH 19:1) to give 623 mg (62%) of a yellow oil, that eventually 
solidified after a few weeks. 
 
20
D][α  = -14.6 (c = 0.84, MeOH), 20436][α  = -26.2 (c = 0.84, MeOH); 1H-NMR (300 MHz, 
CDCl3): δ = 7.98 – 7.84 (m, 4 H), 7.59 (t, J = 7.7 Hz, 1 H), 7.50 – 7.33 (m, 6 H), 7.30 
(d, J = 7.7 Hz, 2 H), 4.56 – 4.38 (m, 4 H), 4.32 – 4.17 (m, 2 H), 3.81 (d, J = 14.3 Hz, 2 
H), 3.68 (d, J = 14.3 Hz, 2 H), 2.90 – 2.74 (m, 2 H), 2.66 – 2.47 (m, 2 H), 2.37 (s, 6 
H). 13C-NMR (75.5 MHz, CDCl3): δ = 164.2, 158.7, 136.8, 131.3, 128.3, 128.2, 127.8, 
121.2, 72.0, 65.4, 64.5, 62.1, 43.5. IR (film): ν~  = 3420, 3076, 2952, 2908, 2845, 
2810, 1970, 1910, 1820, 1645, 1578, 1494, 1450, 1352, 1291, 1253, 1177, 1156, 
1138, 1084, 1053, 1025, 963, 930, 910, 867, 782, 696.  MS (DCI, NH3): m/z (%) = 
485.3 (27), 484.2 (100), 337.1 (7). HRMS (EI): calcd for C29H33N5O2 [M]+ 483.2634, 
found 483.2635. 
 
 
8.3 Complex Synthesis 
 
 
Caution: Although no problems were encountered with the complexes 
described in the following procedures, perchlorates are potential explosives 
and should be handled with care! 
 
 
[Mn(2a)(H2O)2](ClO4)2 * THF 
 
Under N2 403 mg (1.11 mmol, 1.0 equiv.) Mn(ClO4)2*6 H2O and 509 mg (1.11 mmol, 
1.0 equiv.) N(ON)2 were dissolved separately in 10 mL dry THF each. The ligand 
solution was transferred to the metal salt. Precipitation of a colorless solid started 
immediately. After 3 h this was collected on a membrane filter (Schleicher & Schuell, 
RC-L 58, 0.2 µm), washed with THF and dried in vacuo to yield 699 mg (77%) 
colorless solid. 
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M.p. > 200 °C. MS (ESI, CH3CN): m/z (%) = 255.9 [47, [Mn(2a)]2+), 276.5 (100, 
[Mn(2a)(CH3CN)]2+), 458.1 (34, [H2a]+), 611.1 (8, [Mn(2a)(ClO4)]+). C31H39 
Cl2MnN3O15 (819.50): calc. C 45.43, H 4.80, N 5.13; found C 45.24, H 4.84, N 5.24. 
 
[Fe(2a)(H2O)2](ClO4)2 * THF 
 
Under N2 51.2 mg (141 µmol, 1.0 equiv.) Fe(ClO4)2*6 H2O and 64.5 mg (141 µmol, 
1.0 equiv.) N(ON)2 were dissolved separately in 5 mL dry THF each. The ligand 
solution was transferred to the metal salt. Very few of a brown oil separated almost 
immediatelly. The supernatant solution was decanted and left overnight without 
stirring at ambient temperature. A colorless solid separated and was collected on a 
membrane filter (Schleicher & Schuell, RC-L 58, 0.2 µm), washed with Et2O and 
dried in vacuo to yield 50 mg (43%) colorless needles, which were suitable for X-ray-
diffraction. 
 
M.p. 117-119°C (decomp.). MS (ESI, CH3CN): m/z (%) = 256.4 (17, [Fe(2a)]2+), 
458.1 (100, [H2a]+). C31H39Cl2FeN3O15 (820.40): calc. C 45.38, H 4.79, N 5.12; found 
C 45.20, H 4.70, N 5.02. 
 
[Co(2a)](ClO4)2  
 
Under N2 226 mg (616 µmol, 1.0 equiv.) Co(ClO4)2*6 H2O and 282 mg (616 mmol, 
1.0 equiv.) N(ON)2 were dissolved separately in 10 mL dry THF each. The ligand 
solution was transferred to the metal salt. Precipitation of a purple oil started 
immediately. After 3 h the supernatant solution was decanted. The oily residue was 
treated with 10 mL dry THF, followed by decanting. This was repeated twice. After 
drying the residual purple, sticky material overnight in vacuo yielded a purple solid 
(414 mg, 94%).   
 
M.p. > 200°C. MS (ESI, CH3CN): m/z (%) = 257.9 (100, [Co(2a)]2+), 278.5 (10, 
[Co(2a)(CH3CN)]2+),  458.1 (8, [H2a]+), 615.1 (17, [Co(2a)(ClO4)]+. C27H27Cl2CoN3O12 
(715.35): calc. C 45.33, H 3.80, N 5.87; found C 45.17, H 3.98, N 5.75. 
 
[Ni(2a)](ClO4)2 * H2O * THF 
 
Under N2 226 mg (619 µmol, 1.0 equiv.) Ni(ClO4)2*6 H2O and 283 mg (619 mmol, 1.0 
equiv.) N(ON)2 were dissolved separately in 10 mL dry THF each. The ligand solution 
was transferred to the metal salt. Precipitation of a turquoise oil started immediately. 
After 3 h the supernatant solution was decanted. The oily residue was treated with 10 
mL dry THF, followed by decanting. This was repeated twice. After drying the 
residual purple, sticky material overnight in vacuo yielded a turquoise solid (446 mg, 
90%).   
 
M.p. 168-173°C (decomp.). MS (ESI, CH3CN): m/z (%) = 257.4 (20, [Ni(2a)]2+), 278.0 
(100, [Ni(2a)(CH3CN)]2+), 458.1 (22, [H2a]+), 614.1 (100, [Ni(2a)(ClO4)]+ . 
C31H37Cl2N3NiO14 (805.24): calc. C 46.24, H 4.63, N 5.22 ; found C 46.19, H 4.76, N 
5.29. 
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[Cu(2a)](ClO4)2 * H2O * THF 
 
Under N2 230 mg (620 µmol, 1.0 equiv.) Cu(ClO4)2*6 H2O and 284 mg (620 mmol, 
1.0 equiv.) N(ON)2 were dissolved separately in 10 mL dry THF each. The ligand 
solution was transferred to the metal salt. Precipitation of a blue oil started 
immediately. After 3 h the supernatant solution was decanted. The oily residue was 
treated with 10 mL dry THF, followed by decanting. This was repeated twice. After 
drying the residual purple, sticky material overnight in vacuo yielded a light blue solid 
(456 mg, 91%).   
 
M.p. 166-172°C (decomp.). MS (ESI, CH3CN): m/z (%) = 260.0 (98, [Cu(2a)]2+), 
280.5 (100, Cu(2a)(CH3CN)]2+), 458.2 (12, [H2a]+), 520.1 (98, [Cu(2a)]+), 619.2 (79, 
[Cu(2a)(ClO4)]+). C31H37Cl2CuN3O14 (810.09): calc. C 45.96, H 4.60, N 5.19; found C 
45.78, H 4.73, N 5.26. 
 
[CuI(2a)(?)](ClO4) *(?) 
 
Under N2 115 mg (142 µmol, 1.0 equiv.) [Cu(N(ON)2)](ClO4)2 * H2O * THF was 
dissolved in dry CH3CN/MeOH (10mL:20mL). The blue solution was degassed by 
three freeze(N2)-thaw(vaccum)-cycles and 6.0 mg (160 µmol, 1.13 equivs.) NaBH4 
were added. The color changed from light blue to red-brown and a brown solid 
precipitated. After stirring the solution for 18 h at ambient temperature, the solvent 
was removed under vacuum from the yellow solution. The residue was suspended in 
1 mL degassed CDCl3 and the mixture was filtered through a plug of cotton under N2 
into a NMR-tube, which was sealed against atmospheric oxygen. In contrast to the 
corresponding CuII-complex, being paramagnetic, the title compound exhibited 
diamagnetic behavior.  
 
1H-NMR (300 MHz, CDCl3): δ = 8.31 (d, J = 7.4 Hz, 4 H), 7.73 (t, J = 7.7 Hz, 1 H), 
7.65 – 7.39 (m, 6 H), 7.21 (d, J = 7.7 Hz, 2 H), 4.97 – 4.75 (m, 4 H), 4.63 (d, J = 15.6 
Hz, 2 H), 4.47 (d, J = 15.6 Hz, 2 H), 4.19 – 3.95 (m, 4 H), 3.32 – 3.11 (m, 2 H). 13C-
NMR (75.5 MHz, CDCl3): δ = 166.1, 155.8, 138.3, 133.0, 129.0, 128.6, 125.0, 123.1, 
70.9, 70.4, 69.1, 66.9. 
 
After exposure of this solution to the atmosphere for 5 min and closing the NMR-tube 
again, the solution turned green in a matter of seconds and a green precipitate 
formed after several hours. 1H-NMR shows paramagnetic behavior again. Due to this 
reactivity, no further caracterization was carried out. 
 
[Zn(2a)](ClO4)2  
 
Under N2 49.0 mg (132 µmol, 1.0 equiv.) Zn(ClO4)2*6 H2O and 60.2 mg (132 µmol, 
1.0 equiv.) N(ON)2 were dissolved separately in 5 mL dry THF each. The ligand 
solution was transferred to the metal salt. Precipitation of the complex started 
immediately upon addition. The mixture was stirred at ambient temperature for 1 h. 
The precipitate was collected on a membrane filter (Schleicher & Schuell, RC-L 58, 
0.2 µm), washed with THF and dried in vacuo to yield 82 mg (86%) of a colorless 
solid, that was essentially pure. Crystals suitable for X-Ray-diffraction were obtained 
by diffusion of Et2O into a solution of the title compound in CH3CN. 
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M.p. > 200°C. 1H-NMR (300 MHz, CD3CN): δ = 8.12 (t, J = 7.9 Hz, 1 H), 7.88 – 7.75 
(m, 6 H), 7.70 – 7.59 (m, 4 H), 7.48 (d, J = 7.9 Hz, 2 H), 5.06 – 4.88 (m, 4 H), 4.81 (d, 
J = 16.2 Hz, 2 H), 4.44 – 4.16 (m, 6 H), 3.60 – 3.48 (m, 2 H). 13C-NMR (75.5 MHz, 
CD3CN): δ = 175.4, 155.3, 143.7, 135.8, 130.4, 130.3, 124.8, 124.1, 73.7, 73.1, 71.0, 
64.6. MS (ESI, CH3CN): m/z (%) = 260.4 (100, [Zn(2a)]2+), 458.1 (82, [2a]+), 620.1 (7, 
[Zn(2a)(ClO4)]+). C27H27Cl2N3O12Zn (721.81): calc. C 44.93, H 3.77, N 5.82; found C 
45.01, H 3.99, N 5.87. 
 
[Cd(2a)(?)](ClO4)2  
 
Under N2 233 mg (555 µmol, 1.0 equiv.) Cd(ClO4)2*6 H2O and 254 mg (555 µmol, 1.0 
equiv.) N(ON)2 were dissolved separately in 10 mL dry THF each. The ligand solution 
was transferred to the metal salt. Precipitation of the complex started immediately 
upon addition. The mixture was stirred at ambient temperature for 1 h. The 
precipitate was collected on a membrane filter (Schleicher & Schuell, RC-L 58, 0.2 
µm), washed with THF, Et2O and dried in vacuo to yield 427 mg ( %) of a colorless 
solid.  
 
M.p. > 200°C. 1H-NMR (300 MHz, CD3CN): δ = 8.02 (t, J = 7.8 Hz, 1 H), 7.62 – 7.50 
(m, 2 H), 7.48 – 7.30 (m, 10 H), 5.10 – 4.85 (m, 6 H), 4.69 (dd, J = 10.4, 9.3 Hz, 2 H), 
4.29 – 4.15 (m, 4 H), 3.81 (dd, J = 11.1, 8.4 Hz, 2 H), 3.69 – 3.55 (m, 4 H, THF), 1.85 
– 1.72 (m, 4 H, THF). 13C-NMR (75.5 MHz, CD3CN): δ = 170.5, 154.9, 140.8, 134.1, 
129.8, 129.1, 125.7, 122.8, 73.2, 70.4, 70.3, 68.4, 65.9, 26.3. MS (ESI, CH3CN): m/z 
(%) = 285.0 (80, [Cd(2a)]2+), 305.6 (100, [Cd(2a)(CH3CN)]2+), 458.1 (37, [H2a]+), 
670.1 (13, [Cd(2a)(ClO4)]+). No sufficient elemental analysis could be obtained. 
 
[Mg(2a)(H2O)2](ClO4)2 
 
Under N2 267 mg (1.20 mmol, 1.0 equiv.) Mg(ClO4)2 * x H2O and 547 mg (1.20 mmol, 
1.0 equiv.) N(ON)2 were dissolved separately in 10 mL dry THF each. The ligand 
solution was transferred to the metal salt. The solution was stirred at ambient 
temperature for 4 h, before the solvent was removed in vacuo. The slightly yellow 
residue was treated with 20 mL dry Et2O and the suspension was stirred vigorously 
for 1 h. The solid was collected, washed with dry Et2O and dried under reduced 
pressure to yield a slightly yellow solid (596mg, 70%).  
 
M.p. 110-123°C (decomp.). 1H-NMR (300 MHz, CD3CN): very broad signals. MS 
(ESI, CH3CN): m/z (%) = 240.5 (37, [Mg(2a)]2+), 261.0 (100, [Mg(2a)(CH3CN)]2+), 
458.1 (83, [H2a]+), 580.1 (15, [Mg(2a)(ClO4)]+). No sufficient elemental analysis could 
be obtained. 
 
[Fe(2b)(H2O)](ClO4)2 * 2 H2O 
 
Under N2 103 mg (283 µmol, 1.0 equiv.) Fe(ClO4)2*6 H2O and 138 mg (283 µmol, 1.0 
equiv.) N(SN)2 were dissolved separately in 3 mL dry, degassed THF each. The 
ligand solution was transferred to the metal salt. Precipitation of the complex started 
immediately upon addition. The mixture was stirred at ambient temperature for 1 h. 
The supernatant solution was decanted and the residue was treated with 10 mL dry, 
degassed THF, followed by decanting. This was repeated twice and the residual 
brown solid was dried in vacuo to yield 104 (46%) mg of the Fe-complex that was 
stored under N2. 
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M.p. > 100°C (decomp.). MS (ESI, CH3CN): m/z (%) = 272.4 (100, [Fe(2b)]2+), 293.0 
(6, [Fe(2b)(CH3CN)]2+), 490.1 (13, [H2b]+), 644.1 (8, [Fe(2b)(ClO4)]+). C27H33Cl2FeN3 
O13S2 (798.45): calc. C 40.62, H 4.17, N 5.26; found C 40.70, H 4.01, N 5.00. 
 
[Co(2b)(THF)](ClO4)2 * H2O 
 
Under N2 66.7 mg (182 µmol, 1.0 equiv.) Co(ClO4)2*6 H2O and 89.0 mg (182 µmol, 
1.0 equiv.) N(SN)2 were dissolved separately in 5 mL dry THF each. The ligand 
solution was transferred to the metal salt. Precipitation of the complex started 
immediately upon addition. The mixture was stirred at ambient temperature for 1 h. 
The precipitate was collected on a membrane filter (Schleicher & Schuell, RC-L 58, 
0.2 µm), washed with THF and dried in vacuo to yield 138 mg (91%) 
 
M.p. > 100°C (decomp.). MS (ESI, CH3CN): m/z (%) = 273.9 (100, [Co(N(SN)2)]2+), 
490.1 (8, N(SN)2+), 647.0 (5, [Fe(N(SN)2)(ClO4)]+). C31H37Cl2CoN3O12S2 (837.61): 
calc. C 44.45, H 4.45, N 5.02; found C 44.59, H 4.25, N 5.19. 
 
[Ni(2b)](ClO4)2 * 2 H2O 
 
Under N2 62.3 mg (170 µmol, 1.0 equiv.) Ni(ClO4)2*6 H2O and 83.4 mg (170 µmol, 
1.0 equiv.) N(SN)2 were dissolved separately in 5 mL dry THF each. The ligand 
solution was transferred to the metal salt. Precipitation of the complex started 
immediately upon addition. The mixture was stirred at ambient temperature for 20 h. 
The precipitate was collected on a membrane filter (Schleicher & Schuell, RC-L 58, 
0.2 µm), washed with THF and dried in vacuo to yield 120 mg (90%) 
 
M.p. > 179°C (decomp.). MS (ESI, CH3CN): m/z (%) = 273.4 (100, [Ni(N(SN)2)]2+), 
294.0 (12, [Ni(N(SN)2)(CH3CN)]2+), 490.1 (25, N(SN)2+), 646.1 (7, 
[Ni(N(SN)2)(ClO4)]+). C27H31Cl2N3NiO12S2 (783.28): calc. C 41.40, H 3.99, N 5.36; 
found C 41.67, H 4.08, N 5.14. 
 
[Cu(2b)](ClO4)2 * H2O 
 
Under N2 195 mg (526 µmol, 1.0 equiv.) Cu(ClO4)2*6 H2O and 258 mg (526 µmol, 1.0 
equiv.) N(SN)2 were dissolved separately in 10 mL dry THF each. The ligand solution 
was transferred to the metal salt. Precipitation of the complex started immediately 
upon addition. The mixture was stirred at ambient temperature for 1 h, before 20 mL 
dry n-pentane was added. The precipitate was collected on a membrane filter 
(Schleicher & Schuell, RC-L 58, 0.2 µm), washed with THF and dried in vacuo to 
yield 333 mg (82%) 
 
M.p. > 200°C. MS (ESI, CH3CN): m/z (%) = 275.9 (100, [Cu(N(SN)2)]2+), 390.8 (40), 
490.0 (2, [N(SN)2]+), 552.1 (35, [CuI(N(SN)2)]+). C27H29Cl2CuN3O11S2 (770.12): calc. 
C 42.11, H 3.80, N 5.46; found C 41.89, H 3.70, N 5.39. 
 
[CuI(2b)(?)](ClO4) 
 
Under N2 115 mg (93 µmol, 1.0 equiv.) [Cu(N(SN)2)](ClO4)2 * H2O  was dissolved in 
dry CH3CN/MeOH (5mL:10mL). The green solution was degassed by three 
freeze(N2)-thaw(vaccum)-cycles and after complete dissolution 3.5 mg (93 µmol, 
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1.02 equivs.) NaBH4 were added. The color changed from deep green to light-green, 
yellow, orange-brown. After 1 h a bright yellow color had developed again. The 
solvent was removed under vacuum. The residue was suspended in 1 mL degassed 
CDCl3 and the mixture was filtered through a plug of cotton under N2 into a NMR-
tube, which was sealed against atmospheric oxygen. In contrast to the corresponding 
CuII-complex, being paramagnetic, the title compound exhibited diamagnetic 
behavior.  
 
1H-NMR (300 MHz, CDCl3): δ = 8.09 (d, J = 7.1 Hz, 4 H), 7.71 (t, J = 7.7 Hz, 1 H), 
7.49 – 7.19 (m, 8 H), 4.90 – 4.69 (m, 4 H), 4.40 – 4.10 (m, 8 H), 2.53 (dd, J = 14.4, 
10.6 Hz, 2 H), 1.09 (dd, J = 10.6, 5.5 Hz, 2 H). 13C-NMR (75.5 MHz, CDCl3): δ = 
165.5, 156.5, 138.6, 132.7, 128.8, 128.3, 125.5, 123.6, 72.3, 66.6, 38.7, 38.5. MS 
(ESI, CH3CN): m/z (%) = 552.1 (100, [Cu(2b)]+). MS (-ESI, CH3CN): m/z (%) = 751.9 
([Cu(N(SN)2](ClO4)2]-). 
  
After exposure of this solution to the atmosphere for 5 min and closing the NMR-tube 
again, the solution turned green in a matter of hours and a green precipitate formed 
after several days.  
 
[Zn(2b)](ClO4)2 *  H2O  
 
Under N2 193.5 mg (520 µmol, 1.0 equiv.) Zn(ClO4)2*6 H2O and 254.4 mg (520 µmol, 
1.0 equiv.) N(SN)2 were dissolved separately in 10 mL dry THF each. The ligand 
solution was transferred to the metal salt. Precipitation started immediately upon 
addition. The mixture was stirred at ambient temperature for 1 h and 15 mL dry Et2O 
were added. The creamy, slightly sticky solid was collected on a membrane filter 
(Schleicher & Schuell, RC-L 58, 0.2 µm), washed with THF and dried in vacuo to 
yield 323 mg (80%) of a colorless solid, that was essentially pure. Crystals suitable 
for X-Ray-diffraction were obtained by diffusion of Et2O into a solution of the title 
compound in CH3CN. 
 
M.p. > 200°C. 1H-NMR (300 MHz, CD3CN): δ = 8.08 (t, J = 7.7 Hz, 1 H), 7.95 – 7.84 
(m, 4 H), 7.83 – 7.75 (m, 2 H), 7.74 – 7.63 (m, 4 H), 7.58 (d, J = 7.7 Hz, 2 H), 4.98 – 
4.83 (m, 2 H), 4.59 – 4.16 (m, 8 H), 3.30 (dd, J = 14.3, 3.6 Hz, 2 H),  2.93 – 2.73 (m, 
2 H). 13C-NMR (75.5 MHz, CD3CN): δ = 172.7, 156.2, 142.9, 135.7, 130.7, 129.8, 
125.8, 125.7, 74.6, 65.3, 38.5, 38.2. MS (ESI, CH3CN): m/z (%) = 276.4 (100, 
[Zn(2b)]2+), 490.1 (39, [H2b]+), 654.1 (9, [Zn(2b)(ClO4)]+). C27H29Cl2N3O11S2Zn 
(771.96): calc. C 42.01, H 3.79, N 5.44; found C 42.73, H 3.45, N 5.21. 
 
[Cd(2b)](ClO4)2 * THF 
 
Under N2 52.2 mg (124 µmol, 1.0 equiv.) Cd(ClO4)2*6 H2O and 60.9 mg (124 µmol, 
1.0 equiv.) N(SN)2 were dissolved separately in 4 mL dry THF each. The ligand 
solution was transferred to the metal salt. Precipitation of the complex started 
immediately upon addition. The mixture was stirred at ambient temperature for 1 h. 
The precipitate was collected on a membrane filter (Schleicher & Schuell, RC-L 58, 
0.2 µm), washed with THF, Et2O and dried in vacuo to yield 103 mg (95%) of a light 
orange solid.  
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M.p. 162-167°C (decomp.). 1H-NMR (300 MHz, CD3CN): broad signals. MS (ESI, 
CH3CN): m/z (%) = 301.1 (100, [Cd(2b)]2+), 321.6 (12, [Cd(2b)(CH3CN)]2+), 490.1 (7, 
[H2b]+), 702.1 (7, [Cd(2b)(ClO4)]+). C31H35CdCl2N3O11S2 (873.07): calc. C 42.19, H 
4.19, N 4.99; found C 42.65, H 4.04, N 4.81. 
 
[Zn(2c)](ClO4)2 * CH3CN * H2O 
 
Under N2 27.0 mg (72.6 µmol, 1.0 equiv.) Zn(ClO4)2*6 H2O and 35.1 mg (72.6 µmol, 
1.0 equiv.) N(NN)2 were dissolved separately in 2 mL dry THF each. The ligand 
solution was transferred to the metal salt. Precipitation started immediately upon 
addition. The mixture was stirred at ambient temperature for 1 h. The slightly yellow 
solid was collected on a membrane filter (Schleicher & Schuell, RC-L 58, 0.2 µm), 
washed with THF and dried in vacuo. Crystals of  [Zn(N(NN)2)](ClO4)2 * 2 CH3CN, 
suitable for X-Ray-diffraction, were obtained by diffusion of Et2O into a solution of the 
title compound in CH3CN. Upon exposure to air, the crystals replace one CH3CN-
molecule by H2O to yield 35 mg (60%) of the title compound as colorless prisms. 
 
M.p. > 200 °C. 1H-NMR (300 MHz, CD3CN): for spectrum see appendix. MS (ESI, 
CH3CN): m/z (%) = 273.5 (100, [Zn(2c)]2+). C31H38Cl2N6O11Zn (806.96): calc. C 
46.14, H 4.75, N 10.41; found C 46.28, H 4.75, N 10.08. 
 
Co(OTf)2*2 CH3CN 
 
The following procedure was carried out under a dry atmosphere of N2 using 
Schlenk-technique. 935 mg (15.9 mmol, 1.0 equivs.) cobalt (Aldrich, >99.9%, <100 
mesh) were suspended in 16 mL anhydrous CH3CN. The mixture was cooled to 0°C 
and 5.0 g (33.3 mmol, 2.1 equivs.)) triflic acid (Merck-Schuchardt, >98%) were added 
dropwise in the course of 3 min. The icebath was removed and stirring was continued 
for 30 min. After heating the mixture for 2 h under reflux the solvent and excess triflic 
acid were removed under reduced pressure. The solid was dissolved in dry CH3CN 
and residual cobalt was removed by filtration through a pad of Celite 535 (Fluka). The 
resulting red solution was concentrated under reduced pressure until crystallization 
began. The solid was redissolved by adding a minimum amount of dry CH3CN. This 
solution was layered with approximately twice the volume of dry Et2O and allowed to 
stand at room temperature for two days. The formed slightly sticky crystals were 
collected , washed with Et2O and dried in vacuo to constant weight to give a pink 
amorphous powder (5.67g, 81%), that was stored under N2.  
 
IR (nujol): ν~  = 3172 cm-1, 2726, 2675, 2319, 2292, 1310, 1213, 1185, 1039, 722, 
642, 516.  MS (ESI, CH3CN): m/z (%) = 330.8 (100, [Co(CH3CN)3(OTf)]+), 289.7 (74, 
[Co(CH3CN)2(OTf)]+). C6H6CoF6N2O6S2 (439.18): calc. C 16.41, H 1.38, N 6.38, S 
14.60; found C 16.63, H 1.47, N 6.61, S 14.46. 
 
[Co(2b)(THF)](OTf)2 
 
The following procedure was carried out under a dry atmosphere of N2 using 
Schlenk-technique. 113 mg (231 µmol, 1.0 equivs.) N(SN)2 and 101 mg (231 µmol, 
1.0 equivs.) Co(OTf)2*2 CH3CN were dissolved separately in 2.5 mL dry THF each. 
The Co-solution was added to the ligand-solution. A pink solid formed almost 
immediately. The mixture was stirred for additional 3 h. The solid was collected and 
washed with dry THF. Drying the complex under reduced pressure yielded a pink 
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solid (145 mg, 68%). Single-crystals suitable for X-ray analysis were obtained by 
vapour-diffusion of Et2O into a CH3CN-solution of the title compound. 
 
IR (nujol): ν~  = 3162 cm-1, 2725, 2672, 1304, 1154, 1122, 1028, 967, 722, 636.  MS 
(ESI, CH3CN): m/z (%) = 274.1 (100, [Co(2b)]2+). C33H35CoF6N3O9S4 (918.81): calc. 
C 43.14, H 3.84, N 4.57, S 13.96; found C 43.04, H 3.80, N 4.60, S 13.98. 
 
{Ru[N(SN)2]Cl}Cl and {Ru[N(SN)2]CH2Cl2}Cl2 
 
Under N2 a Schlenk-flask was charged with 55.7 mg (111 µmol, 1.0 equivs.) 
[RuCl2(benzene)]2 and 15 mL anhydrous EtOH were added. The suspension was 
treated with 109.1 mg (222.7 µmol, 2.0 equivs.) N(SN)2 and the mixture was heated 
to reflux for 10 h. After cooling down to ambient temperature the solvent was 
removed in vacuo (4 h) and the residue was taken up in 5 mL dry CH2Cl2. The 
resulting yellow-brown solution was passed through a pad of Celite 535 (Fluka) and 
the solvent was removed under reduced pressure again to yield 161 mg of a dark-
yellow solid that consisted of two symmetric diamagnetic RuII-complexes as shown 
by 1H-NMR.  
 
 
1H-NMR (600 MHz, CDCl3): a) [Ru(2b)(?)]Cln: δ = 8.27 (d, J = 7.3 Hz, 4 H), 7.72 – 
7.34 (m, 9 H), 5.30 (s, 2 H), 4.98 (d, J = 18.0 Hz, 2 H), 4.82 – 4.69 (m, 2 H), 4.06 – 
3.94 (m, 2 H), 3.76 (d, J = 18.0 Hz, 2 H), 3.59 – 3.37 (m, 4 H), 2.51 – 2.41 (m, 2 H); 
b) [Ru(2b)Cl]Cl: δ = 8.00 (d, J = 7.5 Hz, 4 H), 7.72 – 7.34 (m, 9 H), 4.82 – 4.69 (m, 2 
H), 4.54 (d, J = 17.0 Hz, 2 H), 4.30 – 4.20 (m, 2 H), 4.06 – 3.94 (m, 2 H), 3.28 – 3.20 
(m, 2 H), 3.08 (d, J = 17.0 Hz, 2 H), 1.82 – 1.72 (m, 2 H). MS (ESI, CH3CN): m/z (%) 
= 315.6 (8, [Ru(2b)(CH3CN)]2+), 626.2 (100, [Ru(2b)Cl]+). 
 
 
[Yb(2a)(H2O)(OTf)](OTf)2 
 
Under N2 289 mg (466 µmol, 1.0 equiv.) Yb(OTf)3 and 213 mg (466 µmol, 1.0 equiv.) 
N(ON)2 were dissolved separately in 5 mL dry THF each. The ligand was transferred 
to the metal and the resulting colorless solution was stirred at ambient temperature 
for 8 h. After refluxing the mixture for 12 h, the orange solution was cooled down and 
the solvent was removed in vacuo. The residue was treated with 25 mL dry Et2O and 
stirred vigorously for 1 h. The solid was collected, washed with dry Et2O and dried 
under reduced pressure to yield 363 mg (71%) of a light orange solid. 
 
M.p. > 100°C (decomp.). MS (ESI, CH3CN): m/z (%) = 344.2 (36, 
[Yb(2a)(OH)(CH3CN)]2+), 398.7 (66, [Yb(2a)(H2O)(OTf)]2+), 419.2 (54, 
[Yb(2a)(H2O)(OTf)(CH3CN)]2+), 458.2 (100, [2a]+), 797.1 (18, [Yb(2a)(OH)(OTf)]+ ), 
947.1 (18, [Yb(2a)(H2O) (OTf)2]+). C30H29F9N3O14 S3Yb (1095.79): calc. C 32.88, H 
2.67, N 3.83; found C 32.51, H 2.90, N 3.83. 
 
∞[Cd(2a)Cl4Cd] (19) 
 
Under N2 a mixture of 319 mg (1.58 mmol, 1.0 equiv.) CdCl2*H2O and 725 mg (1.58 
mmol, 1.0 equiv.) 2a in 20 mL dry MeOH was refluxed for 3 h. After cooling down to 
ambient temperature, the formed white precipitate was collected, washed with cold 
dry MeOH and dried in vacuo to yield 368 mg (57%) of a colorless solid. Crystals 
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suitable for X-ray-analysis were obtained by diffusion of Et2O into a solution of the 
title compound in CH3CN (Note: The title compound was only sparingly soluble in 
CH3CN. Therefore no 13C-NMR could be obtained.) 
 
M.p. > 200 °C. 1H-NMR (300 MHz, CD3CN): δ = 7.94 (t, J = 7.8 Hz, 1 H), 7.75 – 7.59 
(m, 4 H), 7.53 – 7.17 (m, 8 H), 5.10 – 4.87 (m, 6 H), 4.64 (dd, J = 10.4, 9.1 Hz, 2 H), 
4.20 – 4.04 (m, 4 H), 3.73 (dd, J = 11.0, 8.5 Hz, 2 H). MS (ESI, CH3CN): m/z (%) = 
458.1 (58, [2a]+), 606.1 (100, [Cd(2a)Cl]+). MS (-ESI, CH3CN): m/z (%) = 218.3 (100, 
[CdCl3]-). C27H27Cd2Cl4N3O4 (824.14): calc. C 39.35, H 3.30, N 5.10; found C 39.35, 
H 3.40, N 5.17. 
 
∞[Cd(2a)Br4Cd] (20) 
 
Under N2 a mixture of 344 mg (1.26 mmol, 1.0 equiv.) CdBr2 and 578 mg (1.26 mmol, 
1.0 equiv.) 2a in 10 mL dry MeOH was refluxed for 1 h. After cooling down to ambient 
temperatur, the white solid was collected, washed with dry, cold MEOH and dried in 
vacuo to yield 478 mg (76%) of a colorless solid. Crystals suitable for X-ray-analysis 
were obtained by diffusion of Et2O into a solution of the title compound in CH3CN  
 
M.p. > 200°C. 1H-NMR (300 MHz, CD3CN): δ = 7.95 (t, J = 7.9 Hz, 1 H), 7.75 – 7.59 
(m, 4 H), 7.54 – 7.43 (m, 2 H), 7.38 (d, J = 7.9 Hz, 2 H), 7.33 – 7.20 (m, 4 H), 5.08 – 
4.87 (m, 6 H), 4.65 (dd, J = 10.4, 9.1 Hz, 2 H), 4.22 – 4.05 (m, 4 H), 3.76 (t, J = 11.0, 
8.5 Hz, 2 H). 13C-NMR (75.5 MHz, CD3CN): δ = 169.2, 155.2, 140.3, 133.5, 130.3, 
128.7, 126.2, 122.7, 73.6, 70.7, 70.1, 66.2.  MS (ESI, CH3CN): m/z (%) = 458.1 (46, 
[2a]+), 480.1 (100, [Na(2a)]+), 558.1 (11, [Cd3Br4(2a)]2+), 594.1 (6), 650.0 (5, 
[Cd(2a)Br]+). MS (-ESI, CH3CN): m/z (%) = 440.4 (100). C27H27Br4 Cd2N3O4 
(1001.94): calc. C 32.37, H 2.72, N 4.19; found C 32.37, H 2.61, N 4.56. 
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9 Appendix 
 
9.1  NMR-Spectra  
 
2,6-Pyridinedicarboxylic acid dimethyl ester 
 
1H-NMR (300 MHz, CDCl3) 
1.
92
44
0.
98
46
6.
00
00
In
te
gr
al
(ppm)
0.01.02.03.04.05.06.07.08.09.010.0
 13C-NMR (75.5 MHz, CDCl3) 
16
5.
04
10
14
8.
23
10
13
8.
34
61
12
8.
01
20
53
.1
72
6
(ppm)
0102030405060708090100110120130140150160170180190200
 
N
OMeMeO
O O
 
N
OMeMeO
O O
 
 94
2,6-Bis(hydroxymethyl)pyridine (3) 
 
1H-NMR (300 MHz, DMSO-d6) 
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2,6-Bis(bromomethyl)pyridine (10) 
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2,6-Bis(chloromethyl)pyridine Hydrochloride (7) 
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2,6-Bis(chloromethyl)pyridine (8) 
 
1H-NMR (300 MHz, CDCl3) 
1.
00
00
1.
93
75
3.
94
34
In
te
gr
al
(ppm)
0.01.02.03.04.05.06.07.08.09.010.0
 13C-NMR (75.5 MHz, CDCl3) 
15
6.
38
69
13
8.
12
15
12
2.
07
33
46
.4
23
2
(ppm)
0102030405060708090100110120130140150160170180190200
 
 
NCl Cl
NCl Cl
 98
2,6-Bis(carbamimidoylsulfanylmethyl)pyridine Trihydrochloride 
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2,6-Bis(mercaptomethyl)pyridine (11) 
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Ethyl benzimidate (6) 
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(S)-4-Methoxycarbonyl-2-phenyl-oxazoline (15) 
1H-NMR (300 MHz, CDCl3) 
2.
00
34
3.
02
87
1.
00
00
1.
00
97
1.
02
71
3.
04
88
In
te
gr
al
(ppm)
0.01.02.03.04.05.06.07.08.09.010.0
 13C-NMR (75.5 MHz, CDCl3) 
17
1.
60
49
16
6.
24
24
13
1.
84
09
12
8.
55
90
12
8.
32
46
12
6.
90
83
69
.5
23
6
68
.5
95
6
52
.6
84
2
(ppm)
0102030405060708090100110120130140150160170180190200
 
 
 
N
O
O
OCH3
 
N
O
O
OCH3
 
 102
(R)-Hydroxymethyl-2-phenyl-oxazoline (4) 
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(S)-2-Phenyl-4-tosyloxymethyl-oxazoline (17) 
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(S)-2-Phenyl-4-mesyloxymethyl-oxazoline (16) 
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Pyridine-2,6-dicarbaldehyde (12) 
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2,6-Bis(methyliminomethyl)pyridine (13) 
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2,6-Bis(N-methylaminomethyl)pyridine (14) 
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Ligand 2a 
 
1H-NMR (300 MHz, CDCl3) 
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Ligand 2a 
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Ligand 2b 
 
1H-NMR (300 MHz, CDCl3) 
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Ligand 2b 
 
1H-NMR (300 MHz, CD3CN) 
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Ligand 2c 
 
1H-NMR (300 MHz, CDCl3) 
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Ligand  2c 
 
1H-NMR (300 MHz, CD3CN) 
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[CuI(2a)(?)](ClO4) 
 
1H-NMR(300 MHz, CDCl3) 
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[CuI(2b)(?)](ClO4) 
 
1H-NMR(300 MHz, CDCl3) 
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[ZnII(2a)](ClO4)2 
 
1H-NMR (300 MHz, CD3CN) 
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 117
[ZnII(2b)](ClO4)2*H2O 
 
1H-NMR (300 MHz, CD3CN) 
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ZnII(2c)](ClO4)2*H2O*CH3CN 
 
1H-NMR (300 MHz, CD3CN) 
(ppm)
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[CdII(2a)(?)](ClO4)2 
 
1H-NMR (300 MHz, CD3CN) 
1.
03
87
2.
00
00
10
.0
35
6.
03
50
2.
01
97
3.
96
55
1.
98
11
3.
89
84
3.
90
31
In
te
gr
al
(ppm)
0.01.02.03.04.05.06.07.08.09.010.0
 13C-NMR (75.5 MHz, CD3CN) 
17
0.
47
45
15
4.
87
56
14
0.
78
09
13
4.
10
96
12
9.
76
31
12
9.
05
00
12
5.
71
93
12
2.
79
87
73
.1
89
0
70
.4
34
5
70
.2
58
7
68
.3
83
3
65
.8
82
8
26
.3
24
0
(ppm)
0102030405060708090100110120130140150160170180190200
 
 
 120
[Ru(2b)(?)]Cln and [Ru(2b)Cl]Cl  
 
1H-NMR (600 MHz, CDCl3) 
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∞[Cd(2a)Cl4Cd] (19) 
 
1H-NMR (300 MHz, CD3CN) 
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∞[Cd(2a)Br4Cd] (20) 
 
1H-NMR (300 MHz, CD3CN) 
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 123
9.2 Crystal Structures – Selected Data  
 
Selected bond lengths [Å] and angles [°] 
 
[Fe(2a)(H2O)2](ClO4)2*THF  
 
ORTEP-plot of [Fe(2a)(H2O)2]2+ (50% probability level, hydrogens omitted for clarity) 
with atom numbering scheme. 
 
Fe(4)-O(1) 2.111(3)  
Fe(4)-O(2) 2.148(3)  
Fe(4)-O(3) 2.332(3)  
Fe(4)-O(5) 2.336(3)  
Fe(4)-N(1) 2.339(3)  
Fe(4)-N(2) 2.268(3)  
Fe(4)-N(3) 2.232(3) 
 
O(1)-Fe(4)-O(2) 168.99(14)  
O(1)-Fe(4)-O(3) 91.46(10)  
O(1)-Fe(4)-O(5) 82.45(10)  
O(1)-Fe(4)-N(1) 86.02(11)  
O(1)-Fe(4)-N(2) 87.57(12)  
O(1)-Fe(4)-N(3) 98.82(14)  
O(2)-Fe(4)-O(3) 83.94(12)  
O(2)-Fe(4)-O(5) 93.41(12)  
O(2)-Fe(4)-N(1) 82.98(14)  
O(2)-Fe(4)-N(2) 100.26(14)  
O(2)-Fe(4)-N(3) 89.48(15)  
O(3)-Fe(4)-O(5) 133.29(10)  
O(3)-Fe(4)-N(1) 66.92(10)  
O(3)-Fe(4)-N(2) 70.68(10)  
O(3)-Fe(4)-N(3) 154.32(10)  
O(5)-Fe(4)-N(1) 66.47(10)  
O(5)-Fe(4)-N(2) 153.96(10)  
O(5)-Fe(4)-N(3) 71.75(10)  
N(1)-Fe(4)-N(2) 136.89(10)  
N(1)-Fe(4)-N(3) 136.89(10)  
N(2)-Fe(4)-N(3) 86.22(10) 
 124
[Co(2b)(THF)](OTf)2 
 
 
ORTEP-plot of [Co(2b)(THF)]2+ (50% probability level, hydrogens omitted for clarity) 
with atom numbering scheme. 
 
Co(1)-O(35)  2.066(4) 
Co(1)-N(16)  2.106(5) 
Co(1)-N(25)  2.124(5) 
Co(1)-N(8)  2.143(5) 
Co(1)-S(13)  2.4631(17) 
Co(1)-S(22)  2.4800(17) 
 
O(35)-Co(1)-N(16) 179.7(2) 
O(35)-Co(1)-N(25) 92.89(18) 
N(16)-Co(1)-N(25) 87.26(19) 
O(35)-Co(1)-N(8) 92.56(18) 
N(16)-Co(1)-N(8) 87.29(19) 
N(25)-Co(1)-N(8) 174.5(2) 
O(35)-Co(1)-S(13) 97.19(14) 
N(16)-Co(1)-S(13) 82.51(17) 
N(25)-Co(1)-S(13) 97.14(15) 
N(8)-Co(1)-S(13) 82.20(15) 
O(35)-Co(1)-S(22) 97.72(14) 
N(16)-Co(1)-S(22) 82.59(17) 
N(25)-Co(1)-S(22) 80.61(15) 
N(8)-Co(1)-S(22) 98.63(15) 
S(13)-Co(1)-S(22) 165.02(6) 
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[Co(2c)(H2O)](OTf)2 
 
 
ORTEP-plot of [Co(2c)(H2O)]2+ (50% probability level, hydrogens omitted for clarity) 
with atom numbering scheme. 
 
Co(1)-O(37)  2.0250(18) 
Co(1)-N(17)  2.065(2) 
Co(1)-N(27)  2.167(2) 
Co(1)-N(8)  2.220(2) 
Co(1)-N(23)  2.255(2) 
Co(1)-N(13)  2.263(2) 
 
O(37)-Co(1)-N(17) 174.42(9) 
O(37)-Co(1)-N(27) 91.99(7) 
N(17)-Co(1)-N(27) 89.02(8) 
O(37)-Co(1)-N(8) 90.66(7) 
N(17)-Co(1)-N(8) 88.51(7) 
N(27)-Co(1)-N(8) 176.83(9) 
O(37)-Co(1)-N(23) 97.39(8) 
N(17)-Co(1)-N(23) 77.36(9) 
N(27)-Co(1)-N(23) 80.28(8) 
N(8)-Co(1)-N(23) 101.11(8) 
O(37)-Co(1)-N(13) 107.83(8) 
N(17)-Co(1)-N(13) 77.47(9) 
N(27)-Co(1)-N(13) 97.15(8) 
N(8)-Co(1)-N(13) 80.36(8) 
N(23)-Co(1)-N(13) 154.74(8) 
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[Zn(2a)](ClO4)2 
 
ORTEP-plot of [Zn(2a)]2+ (50% probability level, hydrogens omitted for clarity) with 
atom numbering scheme. 
 
Zn(1)-O(1)  2.220 
Zn(1)-O(3)  2.275 
Zn(1)-N(1)  2.031 
Zn(1)-N(2)  1.961 
Zn(1)-N(3)  1.953 
 
O(1)-Zn(1)-O(3) 152.56 
O(1)-Zn(1)-N(1) 76.93  
O(1)-Zn(1)-N(2) 115.31  
O(1)-Zn(1)-N(3) 80.64  
O(3)-Zn(1)-N(1) 76.07  
O(3)-Zn(1)-N(2) 80.43  
O(3)-Zn(1)-N(3) 107.30  
N(1)-Zn(1)-N(2) 113.74  
N(1)-Zn(1)-N(3) 116.45  
N(2)-Zn(1)-N(3) 129.62 
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[Zn(2a)](OTf)2*CH2Cl2 
 
 
ORTEP-plot of [Zn(2a)]2+ (50% probability level, hydrogens omitted for clarity) with 
atom numbering scheme. 
 
Zn(1)-O(1) 2.261(2)  
Zn(1)-O(3) 2.251(2)  
Zn(1)-N(1) 2.031(3)  
Zn(1)-N(2) 1.978(3)  
Zn(1)-N(3) 1.969(3) 
 
O(1)-Zn(1)-O(3) 152.76(9)  
O(1)-Zn(1)-N(1) 76.31(9)  
O(1)-Zn(1)-N(2) 80.22(9)  
O(1)-Zn(1)-N(3) 109.84(9)  
O(3)-Zn(1)-N(1) 76.45(10)  
O(3)-Zn(1)-N(2) 110.96(10)  
O(3)-Zn(1)-N(3) 80.82(10)  
N(1)-Zn(1)-N(2) 113.55(11)  
N(1)-Zn(1)-N(3) 112.44(12)  
N(2)-Zn(1)-N(3) 134.00(12) 
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[Zn(2b)](ClO4)2*H2O 
 
 
ORTEP-plot of [Zn(2b)]2+ (50% probability level, hydrogens omitted for clarity) with 
atom numbering scheme. 
 
Zn(1)-S(1) 2.5299(8)  
Zn(1)-N(1) 2.096(3)  
Zn(1)-N(2) 1.981(3) 
 
S(1)-Zn(1)-N(1) 84.43(2)  
S(1)-Zn(1)-N(2) 83.84(7)  
S(1)-Zn(1)-S(1)#1 168.86(3)  
S(1)-Zn(1)-N(2)#1 100.02(7)  
N(1)-Zn(1)-N(2) 110.12(7)  
S(1)#1-Zn(1)-N(1) 84.43(2)  
N(1)-Zn(1)-N(2)#1 110.12(7)  
S(1)#1-Zn(1)-N(2) 100.02(7)  
N(2)-Zn(1)-N(2)#1 139.76(10)  
S(1)#1-Zn(1)-N(2)#1 83.84(7) 
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[Zn(2c)](ClO4)2*CH3CN*H2O 
 
 
ORTEP-plot of [Zn(2c)]2+ (50% probability level, hydrogens omitted for clarity) with 
atom numbering scheme. 
 
Zn(1)-N(1) 2.025(2)  
Zn(1)-N(2) 2.286(2)  
Zn(1)-N(3) 2.108(2) 
 
N(1)-Zn(1)-N(2) 81.77(9)  
N(1)-Zn(1)-N(3) 119.00(6)  
N(1)-Zn(1)-N(1)#1 122.01(9)  
N(1)-Zn(1)-N(2)#1 112.84(9)  
N(2)-Zn(1)-N(3) 75.36(6)  
N(1)#1-Zn(1)-N(2) 112.84(9)  
N(2)-Zn(1)-N(2)#1 150.73(9)  
N(1)#1-Zn(1)-N(3) 119.00(6)  
N(2)#1-Zn(1)-N(3) 75.36(6)  
N(1)#1-Zn(1)-N(2)#1 81.77(9) 
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{[Cd(2b)(ClO4)](ClO4)}3*CH3CN 
 
 
ORTEP-plot of the three unique units of [Cd(2b)(ClO4)]+ (50% probability level, 
hydrogens omitted for clarity) with atom numbering scheme. 
 
Cd(1)-S(1) 2.6530(17)  Cd(2)-S(3) 2.6454(19)  Cd(3)-S(5) 2.6729(15)  
Cd(1)-S(2) 2.6790(18)  Cd(2)-S(4) 2.6747(18)  Cd(3)-S(6) 2.6838(17)  
Cd(1)-N(1) 2.277(5)  Cd(2)-N(4) 2.347(5)  Cd(3)-N(8) 2.333(5)  
Cd(1)-N(2) 2.416(5)  Cd(2)-N(6) 2.402(5)  Cd(3)-N(7) 2.403(5)  
Cd(1)-N(3) 2.297(5)  Cd(2)-N(5) 2.310(5 Cd(3)-N(9) 2.343(5)  
Cd(1)-O(10)#1 2.609(5)  Cd(2)-O(13) 2.581(5) Cd(3)-O(29)#2 2.392(6)  
 
S(1)-Cd(1)-S(2) 150.16(5)  S(3)-Cd(2)-S(4) 151.36(6)  S(5)-Cd(3)-S(6) 151.62(5)  
S(1)-Cd(1)-N(1) 80.59(14)  S(3)-Cd(2)-N(4) 79.69(12) S(5)-Cd(3)-N(7) 77.26(12)  
S(1)-Cd(1)-N(2) 74.78(13)  S(3)-Cd(2)-N(6) 77.44(13)  S(5)-Cd(3)-N(9) 78.61(12)  
S(1)-Cd(1)-N(3) 108.46(14)  S(3)-Cd(2)-N(5) 102.11(13)  S(5)-Cd(3)-N(8) 101.40(13)  
S(1)-Cd(1)-O(10)#1 80.79(12)  S(3)-Cd(2)-O(13) 128.40(13) S(5)-Cd(3)-O(29)#2 122.49(17)  
S(2)-Cd(1)-N(1) 101.93(13)  S(4)-Cd(2)-N(4) 108.60(13)  S(6)-Cd(3)-N(8) 79.54(13)  
S(2)-Cd(1)-N(2) 75.63(13)  S(4)-Cd(2)-N(6) 74.38(13)  S(6)-Cd(3)-N(7) 74.49(12)  
S(2)-Cd(1)-N(3) 78.49(13)  S(4)-Cd(2)-N(5) 79.68(13)  S(6)-Cd(3)-N(9) 106.20(13)  
S(2)-Cd(1)-O(10)#1 128.96(12)  S(4)-Cd(2)-O(13) 80.16(12)  S(6)-Cd(3)-O(29)#2 85.88(17)  
N(1)-Cd(1)-N(2) 101.89(17)  N(4)-Cd(2)-N(6) 96.99(18)  N(7)-Cd(3)-N(8) 96.83(17)  
N(1)-Cd(1)-N(3) 161.40(18)  N(4)-Cd(2)-N(5) 159.62(17)  N(8)-Cd(3)-N(9) 168.13(18)  
N(2)-Cd(1)-N(3) 96.24(17)  N(5)-Cd(2)-N(6) 103.23(18)  N(7)-Cd(3)-N(9) 94.74(16)  
O(10)#1-Cd(1)-N(1) 77.06(16)  O(13)-Cd(2)-N(4) 84.72(16)  O(29)#2-Cd(3)-N(8) 85.66(17)  
O(10)#1-Cd(1)-N(2) 155.33(17)  O(13)-Cd(2)-N(6) 153.68(17) O(29)#2-Cd(3)-N(7) 159.3(2)  
O(10)#1-Cd(1)-N(3) 88.19(17) O(13)-Cd(2)-N(5) 78.30(16)  O(29)#2-Cd(3)-N(9) 84.43(17)  
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∞[Cd(2a)Cl4Cd] (19) 
 
ORTEP-plot of the two unique units of ∞[Cd(2a)Cl4Cd] (19)  (50% probability level, 
hydrogens omitted for clarity) with atom numbering scheme. 
 
Cd3-N4 2.444(13) Cd1-N1 2.424(13) 
Cd3-O5 2.527(12) Cd1-O1 2.503(9) 
Cd3-O7 2.471(10) Cd1-O3 2.458(9) 
Cd3-N5 2.402(12) Cd1-N2 2.410(11) 
Cd3-N6 2.363(12) Cd1-N3 2.319(12) 
Cd3-Cl5 2.596(4) Cd1-Cl1 2.601(4) 
Cd4-Cl5 2.514(4) Cd2-Cl1 2.503(4) 
Cd4-Cl6 2.520(4) Cd2-Cl2 2.517(4) 
Cd4-Cl7 2.390(5) Cd2-Cl3 2.401(5) 
Cd4-Cl8 2.417(5) Cd2-Cl4 2.407(5) 
 
Cl5-Cd3-O5  86.6(2) Cl1-Cd1-O1 86.5(2)  
Cl5-Cd3-O7 90.1(2) Cl1-Cd1-O3 90.3(2)  
Cl5-Cd3-N4 80.9(2) Cl1-Cd1-N1 83.0(3)  
Cl5-Cd3-N5 88.0(2) Cl1-Cd1-N2 87.4(2)  
Cl5-Cd3-N6 103.7(3) Cl1-Cd1-N3 101.8(3)  
O5-Cd3-O7 128.8(4) O1-Cd1-O3 130.0(4)  
O5-Cd3-N4  65.0(4) O1-Cd1-N1 64.1(4)  
O5-Cd3-N5  68.1(4) O1-Cd1-N2 69.2(4)  
O5-Cd3-N6  158.4(4) O1-Cd1-N3 160.0(4)  
O7-Cd3-N4  64.1(4) O3-Cd1-N1 66.0(4)  
O7-Cd3-N5  162.9(4) O3-Cd1-N2 160.5(3)  
O7-Cd3-N6 70.9(4) O3-Cd1-N3 68.7(4)  
N4-Cd3-N5  132.2(4) N1-Cd1-N2 132.7(4)  
N4-Cd3-N6  134.7(4) N1-Cd1-N3 134.4(4)  
N5-Cd3-N6  93.0(4) N2-Cd1-N3 92.9(4)  
Cl5-Cd4-Cl6  89.24(13) Cl1-Cd2-Cl2 89.03(13)  
Cl5-Cd4-Cl7  116.38(17) Cl1-Cd2-Cl3 115.07(16)  
Cl5-Cd4-Cl8  108.32(17) Cl1-Cd2-Cl4 110.53(17)  
Cl6-Cd4-Cl7 113.92(17) Cl2-Cd2-Cl3 111.97(16)  
Cl6-Cd4-Cl8  108.59(17) Cl2-Cd2-Cl4 107.45(17)  
Cl7-Cd4-Cl8 116.92(19) Cl3-Cd2-Cl4 118.67(17)  
Cd3-Cl5-Cd4 128.78(16) Cd1-Cl1-Cd2 131.01(16) 
Cd3-Cl6-Cd4 132.92(17) Cd1-Cl2-Cd2 130.67(17) 
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∞[Cd(2a)Br4Cd] (20) 
 
 
ORTEP-plot of the two unique units of ∞[Cd(2a)Br4Cd] (20)  (50% probability level, 
hydrogens omitted for clarity) with atom numbering scheme. 
 
Cd1-N1 2.445(5) 
Cd1-O1 2.459(5) 
Cd1-O3 2.507(4) 
Cd1-N2 2.356(6) 
Cd1-N3 2.408(5) 
Cd1-Br1 2.7137(10) 
Cd2-Br1 2.6362(12) 
Cd2-Br2 2.5449(9) 
Cd2-Br3 2.5246(11) 
Cd2-Br4 2.6466(12) 
 
Br1-Cd1-O1  93.65(19) 
Br1-Cd1-O3  80.02(17) 
Br1-Cd1-N1  84.24(19) 
Br1-Cd1-N2  96.7(2) 
Br1-Cd1-N3  92.78(15) 
O1-Cd1-O3  128.49(16) 
O1-Cd1-N1  64.05(18) 
O1-Cd1-N2  69.59(19) 
O1-Cd1-N3  162.28(19) 
O3-Cd1-N1  64.46(18) 
O3-Cd1-N2  161.59(19) 
O3-Cd1-N3  68.96(18) 
N1-Cd1-N2  133.6(2) 
N1-Cd1-N3  133.14(19) 
N2-Cd1-N3  93.3(2) 
Br1-Cd2-Br2  110.07(4) 
Br1-Cd2-Br3  111.08(4) 
Br1-Cd2-Br4  88.29(3) 
Br2-Cd2-Br3  118.78(4) 
Br2-Cd2-Br4  106.54(4) 
Br3-Cd2-Br4  117.89(4) 
 
Cd1-Br1-Cd2 128.66(5) 
Cd1-Br2-Cd2 129.36(5) 
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